| 1 | resulted | 16,468 |
| 2 | participates | 249 |
| 3 | crystallizes | 91 |
| 4 | culminated | 53 |
| 5 | succeeds | 15 |
| 6 | ushered | 14 |
| 7 | -resistance | 3 |
| 8 | osfd-gogat | 3 |
| 9 | anti-progesterones | 2 |
| 10 | artesunate+amodiaquine | 2 |
| 11 | diglucosides | 2 |
| 12 | isting | 2 |
| 13 | kainantu | 2 |
| 14 | lns/min | 2 |
| 15 | mihjam | 2 |
| 16 | ml/min/l | 2 |
| 17 | nh4+-n/l | 2 |
| 18 | oder | 2 |
| 19 | overwintered | 2 |
| 20 | pphcl2 | 2 |
| 21 | r254 | 2 |
| 22 | rietvlei | 2 |
| 23 | stillbirths/abortions | 2 |
| 24 | sult1e1 | 2 |
| 25 | time-to-detection | 2 |
| 26 | ugym2 | 2 |
| 27 | '97 | 1 |
| 28 | 'aggravate | 1 |
| 29 | 'embarrassed | 1 |
| 30 | +3953tt | 1 |
| 31 | +4cm² | 1 |
| 32 | +hsc | 1 |
| 33 | +ifn-a | 1 |
| 34 | -0.15/-0.31 | 1 |
| 35 | -0.2kg | 1 |
| 36 | -0.48±0.11 | 1 |
| 37 | -0.916 | 1 |
| 38 | -10.7±5.1 | 1 |
| 39 | -14103 | 1 |
| 40 | -14242 | 1 |
| 41 | -4.1±1.1 | 1 |
| 42 | -4.2±4.6 | 1 |
| 43 | -5.6±9.2 | 1 |
| 44 | -9.8±6.0 | 1 |
| 45 | -dimer | 1 |
| 46 | -trisindoles | 1 |
| 47 | 0.0417±0.022 | 1 |
| 48 | 0.13+/-0.42 | 1 |
| 49 | 0.13±0.16 | 1 |
| 50 | 0.1g/g | 1 |
| 51 | 0.26±0.2 | 1 |
| 52 | 0.38+/-0.58 | 1 |
| 53 | 0.38±0.10 | 1 |
| 54 | 0.4/100,000 | 1 |
| 55 | 0.41+/-0.71 | 1 |
| 56 | 0.43±0.84 | 1 |
| 57 | 0.45+/-0.24 | 1 |
| 58 | 0.4±1.5 | 1 |
| 59 | 0.5+/-0.2-0.6+/-0.3 | 1 |
| 60 | 0.54-fold | 1 |
| 61 | 0.5mamp | 1 |
| 62 | 0.65-fold | 1 |
| 63 | 0.671+/-0.09 | 1 |
| 64 | 0.68+/-0.2 | 1 |
| 65 | 0.69+/-0.34 | 1 |
| 66 | 0.70:0.30 | 1 |
| 67 | 0.71-5.69 | 1 |
| 68 | 0.72+/-0.3 | 1 |
| 69 | 0.733+/-0.09 | 1 |
| 70 | 0.7365 | 1 |
| 71 | 0.73±0.45 | 1 |
| 72 | 0.80±0.81 | 1 |
| 73 | 0.85/0.15 | 1 |
| 74 | 0.91±0.51 | 1 |
| 75 | 0.93â±0.59 | 1 |
| 76 | 0.9447 | 1 |
| 77 | 0.97-2.43 | 1 |
| 78 | 0.9:0.1 | 1 |
| 79 | 0.9±1.3 | 1 |
| 80 | 05:49 | 1 |
| 81 | 1,2,3,7,8-pebdf | 1 |
| 82 | 1,2-decanediol | 1 |
| 83 | 1,3,5-triarylpyrazolines | 1 |
| 84 | 1,3-diphenylacetone | 1 |
| 85 | 1,4-bq | 1 |
| 86 | 1.09â±0.51 | 1 |
| 87 | 1.12€ | 1 |
| 88 | 1.24+/-0.80 | 1 |
| 89 | 1.25‰ | 1 |
| 90 | 1.2mg/day | 1 |
| 91 | 1.2±0.7888 | 1 |
| 92 | 1.2±1.3 | 1 |
| 93 | 1.31°c | 1 |
| 94 | 1.43±1.1 | 1 |
| 95 | 1.4mg/dl | 1 |
| 96 | 1.4±0.7h | 1 |
| 97 | 1.6±0.97 | 1 |
| 98 | 1.86±0.86 | 1 |
| 99 | 1.88:1 | 1 |
| 100 | 1.8±1.5 | 1 |
| 101 | 1.9±0.2mg/dl | 1 |
| 102 | 1/14,000 | 1 |
| 103 | 1/6400 | 1 |
| 104 | 10,159 | 1 |
| 105 | 10,507 | 1 |
| 106 | 10.1months | 1 |
| 107 | 101.9-128.6 | 1 |
| 108 | 104.17° | 1 |
| 109 | 104.3±19.5 | 1 |
| 110 | 108.9° | 1 |
| 111 | 109.3mm | 1 |
| 112 | 11.14+/-1.19 | 1 |
| 113 | 11.18+/-7.92 | 1 |
| 114 | 11.4±1.19 | 1 |
| 115 | 11.5±7.4mmhg | 1 |
| 116 | 11/237 | 1 |
| 117 | 110/100,000 | 1 |
| 118 | 112.16 | 1 |
| 119 | 113.63+/-12.62 | 1 |
| 120 | 114.9° | 1 |
| 121 | 114/103 | 1 |
| 122 | 115/dl | 1 |
| 123 | 1191.65ml | 1 |
| 124 | 11microm | 1 |
| 125 | 12,471 | 1 |
| 126 | 12.4/1000 | 1 |
| 127 | 12.60ppm | 1 |
| 128 | 12.6±1.3 | 1 |
| 129 | 12.9+/-6.1 | 1 |
| 130 | 12.97±4.33 | 1 |
| 131 | 120,428 | 1 |
| 132 | 12447.7 | 1 |
| 133 | 125,866 | 1 |
| 134 | 128/73 | 1 |
| 135 | 13.77° | 1 |
| 136 | 13/129 | 1 |
| 137 | 130.7±33.4s | 1 |
| 138 | 132/135 | 1 |
| 139 | 1365euro | 1 |
| 140 | 137,815 | 1 |
| 141 | 138.0±15.0beats/min | 1 |
| 142 | 138/100,000 | 1 |
| 143 | 13q21 | 1 |
| 144 | 14-coordinated | 1 |
| 145 | 14.36±2.26mg/dl | 1 |
| 146 | 14.5±1.5 | 1 |
| 147 | 14.8±9.0l | 1 |
| 148 | 14.9+/-9.8 | 1 |
| 149 | 14.93±2.6 | 1 |
| 150 | 144±69.29u/l | 1 |
| 151 | 15.1mm | 1 |
| 152 | 15.7±6.7 | 1 |
| 153 | 1500/mg | 1 |
| 154 | 158-174 | 1 |
| 155 | 159.5μm | 1 |
| 156 | 16,318 | 1 |
| 157 | 16.67±1.77mg/dl | 1 |
| 158 | 16.9+/-6.9 | 1 |
| 159 | 160-180/90-100 | 1 |
| 160 | 162.2pmol/l | 1 |
| 161 | 167/476 | 1 |
| 162 | 169,823 | 1 |
| 163 | 16:0-coa | 1 |
| 164 | 17,730 | 1 |
| 165 | 174/250 | 1 |
| 166 | 179.7mg/kg | 1 |
| 167 | 17beta-trenbolone | 1 |
| 168 | 18-hete | 1 |
| 169 | 18.5±4.1 | 1 |
| 170 | 181s | 1 |
| 171 | 183.65/1000 | 1 |
| 172 | 19,157 | 1 |
| 173 | 19.1h | 1 |
| 174 | 1:118 | 1 |
| 175 | 1:2,200 | 1 |
| 176 | 1:6844 | 1 |
| 177 | 1:8657 | 1 |
| 178 | 1yxa | 1 |
| 179 | 2,5-dhba | 1 |
| 180 | 2-bromoacetamide | 1 |
| 181 | 2-chloro-n-methylacetamide | 1 |
| 182 | 2-methylbutanal | 1 |
| 183 | 2-seconds | 1 |
| 184 | 2.01+/-5.45 | 1 |
| 185 | 2.02â±0.44 | 1 |
| 186 | 2.15±0.79 | 1 |
| 187 | 2.18±0.77 | 1 |
| 188 | 2.3/1000 | 1 |
| 189 | 2.39° | 1 |
| 190 | 2.4-5.6 | 1 |
| 191 | 2.5-3.75mm | 1 |
| 192 | 2.5±6.1° | 1 |
| 193 | 2.77±1.00 | 1 |
| 194 | 2.7±2.2u | 1 |
| 195 | 2.84+/-4.04 | 1 |
| 196 | 2.93±1.11 | 1 |
| 197 | 2.99-7.13 | 1 |
| 198 | 20,131.3-23,574.0 | 1 |
| 199 | 20,254 | 1 |
| 200 | 20.8h | 1 |
| 201 | 20/114 | 1 |
| 202 | 2002/3/31 | 1 |
| 203 | 210/1564 | 1 |
| 204 | 22.6° | 1 |
| 205 | 222,732 | 1 |
| 206 | 225.26±112.95ng/ml | 1 |
| 207 | 2270.5±134.38 | 1 |
| 208 | 2292-bp | 1 |
| 209 | 23,878 | 1 |
| 210 | 23.1±21.4 | 1 |
| 211 | 2300-0700 | 1 |
| 212 | 23nm | 1 |
| 213 | 24,081.1 | 1 |
| 214 | 244+/-31 | 1 |
| 215 | 247,755 | 1 |
| 216 | 256.4±77.80ml | 1 |
| 217 | 26.62±4.88 | 1 |
| 218 | 26.8±11 | 1 |
| 219 | 2611.5 | 1 |
| 220 | 26619 | 1 |
| 221 | 28.4±5.7 | 1 |
| 222 | 29.5+/-8.4 | 1 |
| 223 | 29.66±5.6 | 1 |
| 224 | 298.40±37.77mosm | 1 |
| 225 | 2c18 | 1 |
| 226 | 2·52 | 1 |
| 227 | 3'-hc | 1 |
| 228 | 3,4,5-trimethoxybenzaldehyde | 1 |
| 229 | 3,4-didehydroretinol | 1 |
| 230 | 3,6-anhydrogalactose | 1 |
| 231 | 3,6-dichlorotetrazine | 1 |
| 232 | 3,821 | 1 |
| 233 | 3-amino-5-hydroxypyrazole | 1 |
| 234 | 3-bromo-4-hydroxy-2h-chromen-2-one | 1 |
| 235 | 3-ethoxy-4-hydroxybenzaldehyde | 1 |
| 236 | 3-indolinones | 1 |
| 237 | 3-indolyloxindoles | 1 |
| 238 | 3-methyleneoxindoles | 1 |
| 239 | 3-o-ac-l-rhamnose | 1 |
| 240 | 3-sulfenyl-indoles | 1 |
| 241 | 3.0/0.33 | 1 |
| 242 | 3.0log10cycles | 1 |
| 243 | 3.2+/-6 | 1 |
| 244 | 3.22±0.84 | 1 |
| 245 | 3.25°±2.04° | 1 |
| 246 | 3.30±1.10 | 1 |
| 247 | 3.37-fold | 1 |
| 248 | 3.38/10 | 1 |
| 249 | 3.6±4.1 | 1 |
| 250 | 3.76+/-6.25 | 1 |
| 251 | 3.7±1.3mm | 1 |
| 252 | 3.8±2.8 | 1 |
| 253 | 30-32.5°c | 1 |
| 254 | 30.31±75.85pg/ml | 1 |
| 255 | 300±100c/ml | 1 |
| 256 | 32.03±18.16 | 1 |
| 257 | 32.34±26.83min | 1 |
| 258 | 32.6h | 1 |
| 259 | 32.6±11.7 | 1 |
| 260 | 341,500 | 1 |
| 261 | 35-41°c | 1 |
| 262 | 35.6±3.7 | 1 |
| 263 | 36,791 | 1 |
| 264 | 36.1-49.1 | 1 |
| 265 | 36.2/35.3 | 1 |
| 266 | 38.45±3.3 | 1 |
| 267 | 38.4±11.8 | 1 |
| 268 | 38/57 | 1 |
| 269 | 391-401 | 1 |
| 270 | 3a1/2 | 1 |
| 271 | 3d-ef | 1 |
| 272 | 3·24 | 1 |
| 273 | 4,6'-diacetyl-3,3'-dmbp | 1 |
| 274 | 4-dimethylaminophenol | 1 |
| 275 | 4-phenylsemicarbazide | 1 |
| 276 | 4-steroid | 1 |
| 277 | 4.00±1.61 | 1 |
| 278 | 4.18±1.47 | 1 |
| 279 | 4.1g/g | 1 |
| 280 | 4.1±3.0 | 1 |
| 281 | 4.3±0.53 | 1 |
| 282 | 4.8/100,000 | 1 |
| 283 | 4.9±3.2 | 1 |
| 284 | 40,139€/qaly | 1 |
| 285 | 40,846 | 1 |
| 286 | 41.20 | 1 |
| 287 | 41.7+/-5.6 | 1 |
| 288 | 41.7±8.84 | 1 |
| 289 | 41/11 | 1 |
| 290 | 41:33:18 | 1 |
| 291 | 42:37:19 | 1 |
| 292 | 42±27.9 | 1 |
| 293 | 43.48±15.59 | 1 |
| 294 | 43.4±13.9 | 1 |
| 295 | 43.5±1.1 | 1 |
| 296 | 44,961 | 1 |
| 297 | 44.7/71.2 | 1 |
| 298 | 45.3° | 1 |
| 299 | 4518 | 1 |
| 300 | 46.13±94.70pg/ml | 1 |
| 301 | 485.1 | 1 |
| 302 | 49.5° | 1 |
| 303 | 49months | 1 |
| 304 | 4ebp | 1 |
| 305 | 5,6-positions | 1 |
| 306 | 5,623 | 1 |
| 307 | 5,929.6 | 1 |
| 308 | 5-fluorucacil | 1 |
| 309 | 5-heptyl-substituted | 1 |
| 310 | 5-methylterahydrofolate | 1 |
| 311 | 5.0db | 1 |
| 312 | 5.16±1.04mm | 1 |
| 313 | 5.1±13.4 | 1 |
| 314 | 5.46hz | 1 |
| 315 | 5.6/1,000 | 1 |
| 316 | 5.69±0.30 | 1 |
| 317 | 5.73months | 1 |
| 318 | 51.2+/-6 | 1 |
| 319 | 51.3±22.6 | 1 |
| 320 | 51.4+/-7 | 1 |
| 321 | 52.3±29 | 1 |
| 322 | 52±0.1gr | 1 |
| 323 | 53,601 | 1 |
| 324 | 5345 | 1 |
| 325 | 54,691 | 1 |
| 326 | 54.7±10.1 | 1 |
| 327 | 550±44.2minμg/ml | 1 |
| 328 | 552.86 | 1 |
| 329 | 57,964 | 1 |
| 330 | 57119 | 1 |
| 331 | 58.0±6.4s | 1 |
| 332 | 5898 | 1 |
| 333 | 59.4±9.7 | 1 |
| 334 | 5a1 | 1 |
| 335 | 6.0mm | 1 |
| 336 | 6.0±2.1° | 1 |
| 337 | 6.0±2.24 | 1 |
| 338 | 6.3±0.9 | 1 |
| 339 | 6.3±1.1 | 1 |
| 340 | 6.4days | 1 |
| 341 | 6/30/07 | 1 |
| 342 | 60,000/μl | 1 |
| 343 | 60.0months | 1 |
| 344 | 600mg/d | 1 |
| 345 | 61.1±6.4 | 1 |
| 346 | 642±153minμg/ml | 1 |
| 347 | 65,311-98,160 | 1 |
| 348 | 6503deltt | 1 |
| 349 | 65±31μm | 1 |
| 350 | 667/654 | 1 |
| 351 | 67,882 | 1 |
| 352 | 6894 | 1 |
| 353 | 7.38±0.19 | 1 |
| 354 | 7.54-fold | 1 |
| 355 | 7.60±7.46 | 1 |
| 356 | 7.94±0.41 | 1 |
| 357 | 7/09 | 1 |
| 358 | 7/187 | 1 |
| 359 | 71,103 | 1 |
| 360 | 76.5/56.2 | 1 |
| 361 | 76.75+/-0.4 | 1 |
| 362 | 79,310 | 1 |
| 363 | 79.1±28.1 | 1 |
| 364 | 8,251 | 1 |
| 365 | 8.19±1.79 | 1 |
| 366 | 8.20° | 1 |
| 367 | 8.57+/-1.08 | 1 |
| 368 | 8/200 | 1 |
| 369 | 82.0μm | 1 |
| 370 | 82/124 | 1 |
| 371 | 82days | 1 |
| 372 | 84-fold | 1 |
| 373 | 84/94 | 1 |
| 374 | 8549 | 1 |
| 375 | 8836 | 1 |
| 376 | 8t/8a | 1 |
| 377 | 9.35+/-0.3 | 1 |
| 378 | 9.4±1.3 | 1 |
| 379 | 9.77+/-6.51 | 1 |
| 380 | 9.8g/dl | 1 |
| 381 | 91,215 | 1 |
| 382 | 9163 | 1 |
| 383 | 95,236 | 1 |
| 384 | 9523 | 1 |
| 385 | 97microm | 1 |
| 386 | 9923 | 1 |
| 387 | a-23187 | 1 |
| 388 | a2rbs | 1 |
| 389 | abf2 | 1 |
| 390 | absent/negative | 1 |
| 391 | acidicaldus | 1 |
| 392 | adc-parameters | 1 |
| 393 | adenocarcinona | 1 |
| 394 | ades/adrs | 1 |
| 395 | adipoblasts | 1 |
| 396 | aerobiology | 1 |
| 397 | age-differences | 1 |
| 398 | aggregation-thrombolysis | 1 |
| 399 | ahr/xre | 1 |
| 400 | ala146 | 1 |
| 401 | alkaliphosphatase | 1 |
| 402 | alkyl-pahs | 1 |
| 403 | alkylideneoxindoles | 1 |
| 404 | allyltrimethylsilane | 1 |
| 405 | alpha-amino-nitrogen | 1 |
| 406 | alpha-amylase-activity | 1 |
| 407 | alterability | 1 |
| 408 | ambra-sinto | 1 |
| 409 | amiodarone-and | 1 |
| 410 | anapharm | 1 |
| 411 | angioscanner | 1 |
| 412 | anilinolactones | 1 |
| 413 | antiphlogistica | 1 |
| 414 | apergillosis | 1 |
| 415 | apple-pectin | 1 |
| 416 | arg108 | 1 |
| 417 | arg195 | 1 |
| 418 | arg214 | 1 |
| 419 | arg268 | 1 |
| 420 | argpyrimidine | 1 |
| 421 | arylpropiolamides | 1 |
| 422 | atelactasis | 1 |
| 423 | atg101 | 1 |
| 424 | atg12 | 1 |
| 425 | athsp90.5-7 | 1 |
| 426 | autophagic-responses | 1 |
| 427 | azalydes | 1 |
| 428 | azintamide | 1 |
| 429 | b/yamagata/16/88-like | 1 |
| 430 | balanoides | 1 |
| 431 | bapwv/cca-imt | 1 |
| 432 | bcells | 1 |
| 433 | bee×1.1×1.3-1.5 | 1 |
| 434 | bestent | 1 |
| 435 | beta-1,3-glucanase | 1 |
| 436 | beta-islets | 1 |
| 437 | betadm2 | 1 |
| 438 | blicks | 1 |
| 439 | bloc-ablation | 1 |
| 440 | blp-25 | 1 |
| 441 | bmd/markers/fractures | 1 |
| 442 | bolivians | 1 |
| 443 | bootsma | 1 |
| 444 | brachyteles | 1 |
| 445 | brainstem-cerebellum | 1 |
| 446 | brdu-labeling | 1 |
| 447 | bronchiectasies | 1 |
| 448 | bronchioloectasia | 1 |
| 449 | c-550t | 1 |
| 450 | c-gmp | 1 |
| 451 | c.3124_3133delagcaatatta | 1 |
| 452 | c.3897delt | 1 |
| 453 | c.5114_5117deltaaa | 1 |
| 454 | c.871-2_894del26 | 1 |
| 455 | c.887delc | 1 |
| 456 | c1603t | 1 |
| 457 | c2c3 | 1 |
| 458 | c695t-5 | 1 |
| 459 | ca/creatinine | 1 |
| 460 | cancer-killer | 1 |
| 461 | capitulated | 1 |
| 462 | carbamezepine | 1 |
| 463 | carers/friends | 1 |
| 464 | catabolism/anabolism | 1 |
| 465 | cbl-b | 1 |
| 466 | cc-2 | 1 |
| 467 | ccurred | 1 |
| 468 | cd320 | 1 |
| 469 | cd44/aldh1 | 1 |
| 470 | cdc48p | 1 |
| 471 | cedercholm | 1 |
| 472 | cefroxidine | 1 |
| 473 | cervicalis | 1 |
| 474 | chemo-protectors | 1 |
| 475 | chemorefractoriness | 1 |
| 476 | choelsterol | 1 |
| 477 | cholangiofibrosis | 1 |
| 478 | cinelli | 1 |
| 479 | cineol | 1 |
| 480 | cocos/bacilos | 1 |
| 481 | concentration-profiles | 1 |
| 482 | confided | 1 |
| 483 | conspecific-pecking | 1 |
| 484 | cooled/heated | 1 |
| 485 | coqs/ldl-c | 1 |
| 486 | cost/change | 1 |
| 487 | creedy | 1 |
| 488 | crem | 1 |
| 489 | crept | 1 |
| 490 | crt±cetuximab | 1 |
| 491 | ctz12 | 1 |
| 492 | cundy | 1 |
| 493 | cyfra21 | 1 |
| 494 | cytobacteriology | 1 |
| 495 | cytoheisn-2 | 1 |
| 496 | d165h | 1 |
| 497 | d=0.166 | 1 |
| 498 | dachshund-1 | 1 |
| 499 | daliy | 1 |
| 500 | darkness-and | 1 |
| 501 | dash-resulting | 1 |
| 502 | dbl5 | 1 |
| 503 | dbpcv | 1 |
| 504 | de-investment | 1 |
| 505 | deg/enacs | 1 |
| 506 | dentascan | 1 |
| 507 | deptomycin | 1 |
| 508 | desmethyl-clomipramine | 1 |
| 509 | desmins | 1 |
| 510 | devilish | 1 |
| 511 | dfps | 1 |
| 512 | diabetologists/endocrinologists | 1 |
| 513 | diastolic-dysfunction | 1 |
| 514 | dieter | 1 |
| 515 | dihydroxycholecalciferol | 1 |
| 516 | dipherelin | 1 |
| 517 | disrtict | 1 |
| 518 | disuria | 1 |
| 519 | dolasetron-differ | 1 |
| 520 | downgrafting | 1 |
| 521 | dqb1*03032 | 1 |
| 522 | drug-alone | 1 |
| 523 | dsbt-cbt-cwit | 1 |
| 524 | duerinckx | 1 |
| 525 | dwarf4 | 1 |
| 526 | dyskalemia | 1 |
| 527 | early-diastole | 1 |
| 528 | edendale | 1 |
| 529 | effectiveness¿ | 1 |
| 530 | egfp-14-3-3θ | 1 |
| 531 | encourageable | 1 |
| 532 | entente | 1 |
| 533 | enteronitis | 1 |
| 534 | enynes | 1 |
| 535 | epidermal-growth-factor-concentrations | 1 |
| 536 | euro6020 | 1 |
| 537 | euverted | 1 |
| 538 | ex-pensive | 1 |
| 539 | exacerbative | 1 |
| 540 | exsudativa | 1 |
| 541 | f3'h-activity | 1 |
| 542 | fahrzeugtechnik | 1 |
| 543 | fatten | 1 |
| 544 | fensham | 1 |
| 545 | fibroblast-based | 1 |
| 546 | fibropapillomas | 1 |
| 547 | fkhrl1 | 1 |
| 548 | folfox-b | 1 |
| 549 | foodways | 1 |
| 550 | fraxinea | 1 |
| 551 | freeze-concentrate | 1 |
| 552 | friedrichschafen | 1 |
| 553 | ft-nmr | 1 |
| 554 | fufox | 1 |
| 555 | fv1x | 1 |
| 556 | g87 | 1 |
| 557 | gabbe | 1 |
| 558 | galacturonate | 1 |
| 559 | gases/fumes | 1 |
| 560 | gender-weights | 1 |
| 561 | gene-scaffolds | 1 |
| 562 | gezondheid | 1 |
| 563 | gh14-3-3h | 1 |
| 564 | gh90 | 1 |
| 565 | glu149 | 1 |
| 566 | gluconeogenesis/glycolysis | 1 |
| 567 | glucosine | 1 |
| 568 | gly128→asp | 1 |
| 569 | glycyltryptophanylglycylglycine | 1 |
| 570 | goldis | 1 |
| 571 | gpmk1 | 1 |
| 572 | gps'reports | 1 |
| 573 | grizzard | 1 |
| 574 | group/attrition | 1 |
| 575 | gtl2-2 | 1 |
| 576 | haptoglobulin | 1 |
| 577 | healthy-controls | 1 |
| 578 | heme-chromophores | 1 |
| 579 | hemianopsia | 1 |
| 580 | hemolysis-and | 1 |
| 581 | hendrickse | 1 |
| 582 | hepatosplenomegly | 1 |
| 583 | his248 | 1 |
| 584 | hisaralan | 1 |
| 585 | hnrnp-k | 1 |
| 586 | hot-flushes | 1 |
| 587 | hpv/hiv | 1 |
| 588 | hsfc2 | 1 |
| 589 | hsl-mrnas | 1 |
| 590 | hydroxo-bridges | 1 |
| 591 | hyper-leukocytes | 1 |
| 592 | hyper-lipidemia | 1 |
| 593 | hyperfibrogenemia | 1 |
| 594 | hyperlipogensisi | 1 |
| 595 | hyperlipoidemia | 1 |
| 596 | hypoadiponectin | 1 |
| 597 | h₂wo₄ | 1 |
| 598 | i-troponin | 1 |
| 599 | ibotenate | 1 |
| 600 | idmtx | 1 |
| 601 | igfs/igfbps | 1 |
| 602 | ikji | 1 |
| 603 | il-0.05 | 1 |
| 604 | il-8-values | 1 |
| 605 | immaging | 1 |
| 606 | implimented | 1 |
| 607 | inductest | 1 |
| 608 | inter-acting | 1 |
| 609 | interleukin-lβ | 1 |
| 610 | interleukin‑6 | 1 |
| 611 | interpenetrate | 1 |
| 612 | intervente | 1 |
| 613 | interventi | 1 |
| 614 | intra-abomasally | 1 |
| 615 | intra-canalicular | 1 |
| 616 | intrusion-distress | 1 |
| 617 | iodid | 1 |
| 618 | irctimbalance | 1 |
| 619 | irreplaceability | 1 |
| 620 | irreproductible | 1 |
| 621 | isheri-igando | 1 |
| 622 | jin-ye | 1 |
| 623 | kawangware | 1 |
| 624 | kers | 1 |
| 625 | knights | 1 |
| 626 | knowhow | 1 |
| 627 | kucing | 1 |
| 628 | l-b6 | 1 |
| 629 | lat3 | 1 |
| 630 | leucyl-histidylhydrazide | 1 |
| 631 | levatroplasty | 1 |
| 632 | lh-responsiveness | 1 |
| 633 | li-may | 1 |
| 634 | lieing | 1 |
| 635 | light-reaction | 1 |
| 636 | lipoperoxidase | 1 |
| 637 | lizhong-tang | 1 |
| 638 | low-dose-heparin | 1 |
| 639 | low-likers | 1 |
| 640 | lpin1-β | 1 |
| 641 | lymphadentis | 1 |
| 642 | lys-240 | 1 |
| 643 | lys51/56/53 | 1 |
| 644 | m-helices | 1 |
| 645 | m3c | 1 |
| 646 | maccleod | 1 |
| 647 | madias | 1 |
| 648 | maibi | 1 |
| 649 | malignoma | 1 |
| 650 | maltodextrin-glucose | 1 |
| 651 | mapk/p38 | 1 |
| 652 | mate-2k | 1 |
| 653 | mathias | 1 |
| 654 | mazury | 1 |
| 655 | mckhann | 1 |
| 656 | meldoniya | 1 |
| 657 | membrane-specifically | 1 |
| 658 | meopa | 1 |
| 659 | meta-analyses.2 | 1 |
| 660 | metallisation | 1 |
| 661 | metamaks | 1 |
| 662 | mglur-signaling | 1 |
| 663 | microholes | 1 |
| 664 | micronucleation | 1 |
| 665 | microparticulates | 1 |
| 666 | microperforations | 1 |
| 667 | middle-methylation | 1 |
| 668 | mineralocorticoid-receptor-antagonists | 1 |
| 669 | mir-199 | 1 |
| 670 | mir-486 | 1 |
| 671 | misgrated | 1 |
| 672 | mnf3 | 1 |
| 673 | mnur | 1 |
| 674 | monosialoganglioside | 1 |
| 675 | mother's/mother | 1 |
| 676 | mptms | 1 |
| 677 | msrc | 1 |
| 678 | mtx-groups | 1 |
| 679 | muconolactone | 1 |
| 680 | multi-leaf-collimators | 1 |
| 681 | multiplexer/demultiplexer | 1 |
| 682 | murad® | 1 |
| 683 | musculoskeletal-based | 1 |
| 684 | mx97-8147 | 1 |
| 685 | mycoplasmas-positive | 1 |
| 686 | myeloperoxidation | 1 |
| 687 | myofibroproliferation | 1 |
| 688 | n-alkylisatins | 1 |
| 689 | n512 | 1 |
| 690 | n=2188 | 1 |
| 691 | nagana | 1 |
| 692 | nanoaggregates | 1 |
| 693 | nanoencapsuted | 1 |
| 694 | nc-n | 1 |
| 695 | necrosis/fibrosis | 1 |
| 696 | neosporosis | 1 |
| 697 | nerve/plexus | 1 |
| 698 | neurecover-sa | 1 |
| 699 | nfκb-activation | 1 |
| 700 | nifuroxime | 1 |
| 701 | nitrite-anions | 1 |
| 702 | no-shunts | 1 |
| 703 | nodvocain | 1 |
| 704 | noise/oversensing | 1 |
| 705 | non-access-related | 1 |
| 706 | non-acquirers | 1 |
| 707 | non-coercively | 1 |
| 708 | non-malignancy | 1 |
| 709 | non-rejection | 1 |
| 710 | non-ring-wearers | 1 |
| 711 | non-supplementation | 1 |
| 712 | nonring-wearers | 1 |
| 713 | nonself-antigens | 1 |
| 714 | nonsmokers-participated | 1 |
| 715 | nonstationarities | 1 |
| 716 | numbness/tingling | 1 |
| 717 | o-h12 | 1 |
| 718 | oatp1b3/slco1b3 | 1 |
| 719 | of/kinks | 1 |
| 720 | ofprp | 1 |
| 721 | ofstatins | 1 |
| 722 | omega-c | 1 |
| 723 | ona-ma | 1 |
| 724 | oogonia | 1 |
| 725 | opitz | 1 |
| 726 | oprh | 1 |
| 727 | osgdh3 | 1 |
| 728 | oshsfc1b | 1 |
| 729 | oshsp18.0 | 1 |
| 730 | ossos1 | 1 |
| 731 | otorrhagia | 1 |
| 732 | outcome- | 1 |
| 733 | over-eruption | 1 |
| 734 | over-exuberance | 1 |
| 735 | overall-mortality | 1 |
| 736 | p.e4181k | 1 |
| 737 | p.e767fs | 1 |
| 738 | p.q201h | 1 |
| 739 | p.ser615leu | 1 |
| 740 | p.v600k | 1 |
| 741 | p97.5 | 1 |
| 742 | pacemaker-induced | 1 |
| 743 | pakt1 | 1 |
| 744 | pank4 | 1 |
| 745 | paribus | 1 |
| 746 | pastaza | 1 |
| 747 | pb-rb | 1 |
| 748 | pc-kus | 1 |
| 749 | pecfent® | 1 |
| 750 | peer-moderation | 1 |
| 751 | pellinos | 1 |
| 752 | penicillin-v | 1 |
| 753 | perturbances | 1 |
| 754 | pharmaco-electroencephalography | 1 |
| 755 | phase-changes | 1 |
| 756 | phe-phe-nh2 | 1 |
| 757 | phe55 | 1 |
| 758 | phenyle-phrine | 1 |
| 759 | phenylethyl-itc | 1 |
| 760 | phenylyalanine | 1 |
| 761 | phosphatemic | 1 |
| 762 | phospho-syk | 1 |
| 763 | phosphorylated-cjun | 1 |
| 764 | phosphorylated-s6 | 1 |
| 765 | pieber | 1 |
| 766 | pilot-implementation | 1 |
| 767 | pin-stripping | 1 |
| 768 | planterflexors | 1 |
| 769 | plasmacytogenesis | 1 |
| 770 | plausibility.the | 1 |
| 771 | plethsmography | 1 |
| 772 | polymagma | 1 |
| 773 | post-aes | 1 |
| 774 | post-ecls | 1 |
| 775 | post-egfr | 1 |
| 776 | post-wbv | 1 |
| 777 | post-whisper | 1 |
| 778 | pound1,458,268,104 | 1 |
| 779 | ppar-α-γ | 1 |
| 780 | preparation-transplantation | 1 |
| 781 | pretarsus | 1 |
| 782 | pro-mmp-13 | 1 |
| 783 | procinetics | 1 |
| 784 | procitis | 1 |
| 785 | programs-particularly | 1 |
| 786 | proteinuira | 1 |
| 787 | provements | 1 |
| 788 | pseudomonadales | 1 |
| 789 | pulmonary-pleurostaphylococci | 1 |
| 790 | purpald® | 1 |
| 791 | pvwy | 1 |
| 792 | quadruparesis | 1 |
| 793 | quasi-3.36-level | 1 |
| 794 | r1628p | 1 |
| 795 | r73 | 1 |
| 796 | railings | 1 |
| 797 | re-enrolling | 1 |
| 798 | re-packed | 1 |
| 799 | re-recorded | 1 |
| 800 | reality-oriented | 1 |
| 801 | reduced/eliminated | 1 |
| 802 | reengulfment | 1 |
| 803 | reenrolling | 1 |
| 804 | rehydrolyzation | 1 |
| 805 | repeat-hltx | 1 |
| 806 | resisting-pain | 1 |
| 807 | resorbs | 1 |
| 808 | responsibilities-and | 1 |
| 809 | retranslocated | 1 |
| 810 | retroplastic | 1 |
| 811 | retrospectivity | 1 |
| 812 | revengeful | 1 |
| 813 | rhli | 1 |
| 814 | rice/pasta | 1 |
| 815 | rmopr | 1 |
| 816 | ro-115-1240 | 1 |
| 817 | rollerblades | 1 |
| 818 | rouges | 1 |
| 819 | rowed | 1 |
| 820 | rs1063539 | 1 |
| 821 | rs1176713-gg | 1 |
| 822 | rs1517618 | 1 |
| 823 | rs1569480 | 1 |
| 824 | rs16944 | 1 |
| 825 | rs17129561 | 1 |
| 826 | rs17614942-ac | 1 |
| 827 | rs2293286 | 1 |
| 828 | rs3743527 | 1 |
| 829 | rs3820185 | 1 |
| 830 | rs3887412 | 1 |
| 831 | rs4525 | 1 |
| 832 | rs6795970 | 1 |
| 833 | rs7801617 | 1 |
| 834 | rs9402349 | 1 |
| 835 | rs9458172 | 1 |
| 836 | rs9902941 | 1 |
| 837 | rsus | 1 |
| 838 | rtp4 | 1 |
| 839 | rubiales | 1 |
| 840 | rv-sr | 1 |
| 841 | s9-enhancing | 1 |
| 842 | sanou | 1 |
| 843 | sc-40230 | 1 |
| 844 | scientists/bhp | 1 |
| 845 | sdldl/lhdl | 1 |
| 846 | secretorum | 1 |
| 847 | selectiveness | 1 |
| 848 | self-representation | 1 |
| 849 | senataxin | 1 |
| 850 | ser-171 | 1 |
| 851 | ser353 | 1 |
| 852 | ser65cys/wt | 1 |
| 853 | ser80-to-ile | 1 |
| 854 | sif4 | 1 |
| 855 | simvasatin | 1 |
| 856 | simvastatin-differ | 1 |
| 857 | simvastatin-used | 1 |
| 858 | sirt7 | 1 |
| 859 | sitcom | 1 |
| 860 | sociale | 1 |
| 861 | solidus | 1 |
| 862 | sparcity | 1 |
| 863 | spectially | 1 |
| 864 | sreepur | 1 |
| 865 | srlong | 1 |
| 866 | st-elevations | 1 |
| 867 | stat-4 | 1 |
| 868 | sub-chorionitis | 1 |
| 869 | sucesso | 1 |
| 870 | superbroadly | 1 |
| 871 | swertiamarian | 1 |
| 872 | symptom-generating | 1 |
| 873 | symtomps | 1 |
| 874 | synaptotoxicity | 1 |
| 875 | syphillis | 1 |
| 876 | t219a | 1 |
| 877 | t80a-a90g | 1 |
| 878 | tag-positioning | 1 |
| 879 | talukas | 1 |
| 880 | texturizer | 1 |
| 881 | tgf-βr1 | 1 |
| 882 | tgf-‑β1 | 1 |
| 883 | thermostresses | 1 |
| 884 | thr-603 | 1 |
| 885 | thr105ile | 1 |
| 886 | tips-ebx* | 1 |
| 887 | tn6222 | 1 |
| 888 | tnpo | 1 |
| 889 | tone-sweeps | 1 |
| 890 | tongnaab | 1 |
| 891 | toparticipate | 1 |
| 892 | trans-2-hexenal | 1 |
| 893 | transformation-metabolism | 1 |
| 894 | treg-cells | 1 |
| 895 | trerapy | 1 |
| 896 | triangulatus | 1 |
| 897 | triatomids | 1 |
| 898 | trivette | 1 |
| 899 | trp283 | 1 |
| 900 | tsh-level | 1 |
| 901 | ttatg8s | 1 |
| 902 | tulokas | 1 |
| 903 | tuszyński | 1 |
| 904 | tyr-105 | 1 |
| 905 | tyr1173 | 1 |
| 906 | tyr224 | 1 |
| 907 | u2os/mtx300 | 1 |
| 908 | ubiaja | 1 |
| 909 | ufh/vkas | 1 |
| 910 | ugt1a9/2b7 | 1 |
| 911 | ul47 | 1 |
| 912 | ultrastability | 1 |
| 913 | uncoil | 1 |
| 914 | under-achieve | 1 |
| 915 | underachieving | 1 |
| 916 | undercontrolled | 1 |
| 917 | underprovided | 1 |
| 918 | uniocularly | 1 |
| 919 | unsaturations | 1 |
| 920 | up-stage | 1 |
| 921 | urea-nitrogen | 1 |
| 922 | uretero-ileal | 1 |
| 923 | urethritis-especially | 1 |
| 924 | uroprotection | 1 |
| 925 | urosepsis/death | 1 |
| 926 | uv-susceptibility | 1 |
| 927 | vad-volunteers | 1 |
| 928 | vegf-d/vegfr-3 | 1 |
| 929 | vegfr2-promoters | 1 |
| 930 | verteporfin-pdt | 1 |
| 931 | viferon | 1 |
| 932 | vigabatrine | 1 |
| 933 | violet-light | 1 |
| 934 | volatisation | 1 |
| 935 | vortexing | 1 |
| 936 | vs.vancomycin | 1 |
| 937 | waitresses | 1 |
| 938 | wenereology | 1 |
| 939 | whang | 1 |
| 940 | wobbles | 1 |
| 941 | wobbling | 1 |
| 942 | xilooligosaccharides | 1 |
| 943 | y654-beta-catenin | 1 |
| 944 | yoyoirt2 | 1 |
| 945 | zareba | 1 |
| 946 | zexanthin | 1 |
| 947 | ~2.7-fold | 1 |
| 948 | ~27-fold | 1 |
| 949 | ~410 | 1 |
| 950 | ~70-fold | 1 |
| 951 | £10,148/qaly | 1 |
| 952 | £1560.21 | 1 |
| 953 | £242.20 | 1 |
| 954 | £496,556 | 1 |
| 955 | ¥41 | 1 |
| 956 | çatağıl | 1 |
| 957 | β-esterases | 1 |
| 958 | βcys241 | 1 |
| 959 | δamylin30/δglucose30 | 1 |
| 960 | δfm-ul | 1 |
| 961 | δsto2 | 1 |
| 962 | ε-lactones | 1 |
| 963 | €/year | 1 |
| 964 | €113 | 1 |
| 965 | €115 | 1 |
| 966 | €16,438/qaly | 1 |
| 967 | €2,488 | 1 |
| 968 | €27,885 | 1 |
| 969 | €28 | 1 |
| 970 | €375 | 1 |
| 971 | €3830/woman | 1 |
| 972 | €4,828 | 1 |
| 973 | €4576 | 1 |
| 974 | €6857 | 1 |
| 975 | ∼135-fold | 1 |
| 976 | ≤20/50 | 1 |
| 977 | ≥67° | 1 |
| 978 | ≥90cm | 1 |
| 1 | '97 | 1 |
| 2 | 'aggravate | 1 |
| 3 | 'embarrassed | 1 |
| 4 | +3953tt | 1 |
| 5 | +4cm² | 1 |
| 6 | +hsc | 1 |
| 7 | +ifn-a | 1 |
| 8 | -0.15/-0.31 | 1 |
| 9 | -0.2kg | 1 |
| 10 | -0.48±0.11 | 1 |
| 11 | -0.916 | 1 |
| 12 | -10.7±5.1 | 1 |
| 13 | -14103 | 1 |
| 14 | -14242 | 1 |
| 15 | -4.1±1.1 | 1 |
| 16 | -4.2±4.6 | 1 |
| 17 | -5.6±9.2 | 1 |
| 18 | -9.8±6.0 | 1 |
| 19 | -dimer | 1 |
| 20 | -resistance | 3 |
| 21 | -trisindoles | 1 |
| 22 | 0.0417±0.022 | 1 |
| 23 | 0.13+/-0.42 | 1 |
| 24 | 0.13±0.16 | 1 |
| 25 | 0.1g/g | 1 |
| 26 | 0.26±0.2 | 1 |
| 27 | 0.38+/-0.58 | 1 |
| 28 | 0.38±0.10 | 1 |
| 29 | 0.4/100,000 | 1 |
| 30 | 0.41+/-0.71 | 1 |
| 31 | 0.43±0.84 | 1 |
| 32 | 0.45+/-0.24 | 1 |
| 33 | 0.4±1.5 | 1 |
| 34 | 0.5+/-0.2-0.6+/-0.3 | 1 |
| 35 | 0.54-fold | 1 |
| 36 | 0.5mamp | 1 |
| 37 | 0.65-fold | 1 |
| 38 | 0.671+/-0.09 | 1 |
| 39 | 0.68+/-0.2 | 1 |
| 40 | 0.69+/-0.34 | 1 |
| 41 | 0.70:0.30 | 1 |
| 42 | 0.71-5.69 | 1 |
| 43 | 0.72+/-0.3 | 1 |
| 44 | 0.733+/-0.09 | 1 |
| 45 | 0.7365 | 1 |
| 46 | 0.73±0.45 | 1 |
| 47 | 0.80±0.81 | 1 |
| 48 | 0.85/0.15 | 1 |
| 49 | 0.91±0.51 | 1 |
| 50 | 0.93â±0.59 | 1 |
| 51 | 0.9447 | 1 |
| 52 | 0.97-2.43 | 1 |
| 53 | 0.9:0.1 | 1 |
| 54 | 0.9±1.3 | 1 |
| 55 | 05:49 | 1 |
| 56 | 1,2,3,7,8-pebdf | 1 |
| 57 | 1,2-decanediol | 1 |
| 58 | 1,3,5-triarylpyrazolines | 1 |
| 59 | 1,3-diphenylacetone | 1 |
| 60 | 1,4-bq | 1 |
| 61 | 1.09â±0.51 | 1 |
| 62 | 1.12€ | 1 |
| 63 | 1.24+/-0.80 | 1 |
| 64 | 1.25‰ | 1 |
| 65 | 1.2mg/day | 1 |
| 66 | 1.2±0.7888 | 1 |
| 67 | 1.2±1.3 | 1 |
| 68 | 1.31°c | 1 |
| 69 | 1.43±1.1 | 1 |
| 70 | 1.4mg/dl | 1 |
| 71 | 1.4±0.7h | 1 |
| 72 | 1.6±0.97 | 1 |
| 73 | 1.86±0.86 | 1 |
| 74 | 1.88:1 | 1 |
| 75 | 1.8±1.5 | 1 |
| 76 | 1.9±0.2mg/dl | 1 |
| 77 | 1/14,000 | 1 |
| 78 | 1/6400 | 1 |
| 79 | 10,159 | 1 |
| 80 | 10,507 | 1 |
| 81 | 10.1months | 1 |
| 82 | 101.9-128.6 | 1 |
| 83 | 104.17° | 1 |
| 84 | 104.3±19.5 | 1 |
| 85 | 108.9° | 1 |
| 86 | 109.3mm | 1 |
| 87 | 11.14+/-1.19 | 1 |
| 88 | 11.18+/-7.92 | 1 |
| 89 | 11.4±1.19 | 1 |
| 90 | 11.5±7.4mmhg | 1 |
| 91 | 11/237 | 1 |
| 92 | 110/100,000 | 1 |
| 93 | 112.16 | 1 |
| 94 | 113.63+/-12.62 | 1 |
| 95 | 114.9° | 1 |
| 96 | 114/103 | 1 |
| 97 | 115/dl | 1 |
| 98 | 1191.65ml | 1 |
| 99 | 11microm | 1 |
| 100 | 12,471 | 1 |
| 101 | 12.4/1000 | 1 |
| 102 | 12.60ppm | 1 |
| 103 | 12.6±1.3 | 1 |
| 104 | 12.9+/-6.1 | 1 |
| 105 | 12.97±4.33 | 1 |
| 106 | 120,428 | 1 |
| 107 | 12447.7 | 1 |
| 108 | 125,866 | 1 |
| 109 | 128/73 | 1 |
| 110 | 13.77° | 1 |
| 111 | 13/129 | 1 |
| 112 | 130.7±33.4s | 1 |
| 113 | 132/135 | 1 |
| 114 | 1365euro | 1 |
| 115 | 137,815 | 1 |
| 116 | 138.0±15.0beats/min | 1 |
| 117 | 138/100,000 | 1 |
| 118 | 13q21 | 1 |
| 119 | 14-coordinated | 1 |
| 120 | 14.36±2.26mg/dl | 1 |
| 121 | 14.5±1.5 | 1 |
| 122 | 14.8±9.0l | 1 |
| 123 | 14.9+/-9.8 | 1 |
| 124 | 14.93±2.6 | 1 |
| 125 | 144±69.29u/l | 1 |
| 126 | 15.1mm | 1 |
| 127 | 15.7±6.7 | 1 |
| 128 | 1500/mg | 1 |
| 129 | 158-174 | 1 |
| 130 | 159.5μm | 1 |
| 131 | 16,318 | 1 |
| 132 | 16.67±1.77mg/dl | 1 |
| 133 | 16.9+/-6.9 | 1 |
| 134 | 160-180/90-100 | 1 |
| 135 | 162.2pmol/l | 1 |
| 136 | 167/476 | 1 |
| 137 | 169,823 | 1 |
| 138 | 16:0-coa | 1 |
| 139 | 17,730 | 1 |
| 140 | 174/250 | 1 |
| 141 | 179.7mg/kg | 1 |
| 142 | 17beta-trenbolone | 1 |
| 143 | 18-hete | 1 |
| 144 | 18.5±4.1 | 1 |
| 145 | 181s | 1 |
| 146 | 183.65/1000 | 1 |
| 147 | 19,157 | 1 |
| 148 | 19.1h | 1 |
| 149 | 1:118 | 1 |
| 150 | 1:2,200 | 1 |
| 151 | 1:6844 | 1 |
| 152 | 1:8657 | 1 |
| 153 | 1yxa | 1 |
| 154 | 2,5-dhba | 1 |
| 155 | 2-bromoacetamide | 1 |
| 156 | 2-chloro-n-methylacetamide | 1 |
| 157 | 2-methylbutanal | 1 |
| 158 | 2-seconds | 1 |
| 159 | 2.01+/-5.45 | 1 |
| 160 | 2.02â±0.44 | 1 |
| 161 | 2.15±0.79 | 1 |
| 162 | 2.18±0.77 | 1 |
| 163 | 2.3/1000 | 1 |
| 164 | 2.39° | 1 |
| 165 | 2.4-5.6 | 1 |
| 166 | 2.5-3.75mm | 1 |
| 167 | 2.5±6.1° | 1 |
| 168 | 2.77±1.00 | 1 |
| 169 | 2.7±2.2u | 1 |
| 170 | 2.84+/-4.04 | 1 |
| 171 | 2.93±1.11 | 1 |
| 172 | 2.99-7.13 | 1 |
| 173 | 20,131.3-23,574.0 | 1 |
| 174 | 20,254 | 1 |
| 175 | 20.8h | 1 |
| 176 | 20/114 | 1 |
| 177 | 2002/3/31 | 1 |
| 178 | 210/1564 | 1 |
| 179 | 22.6° | 1 |
| 180 | 222,732 | 1 |
| 181 | 225.26±112.95ng/ml | 1 |
| 182 | 2270.5±134.38 | 1 |
| 183 | 2292-bp | 1 |
| 184 | 23,878 | 1 |
| 185 | 23.1±21.4 | 1 |
| 186 | 2300-0700 | 1 |
| 187 | 23nm | 1 |
| 188 | 24,081.1 | 1 |
| 189 | 244+/-31 | 1 |
| 190 | 247,755 | 1 |
| 191 | 256.4±77.80ml | 1 |
| 192 | 26.62±4.88 | 1 |
| 193 | 26.8±11 | 1 |
| 194 | 2611.5 | 1 |
| 195 | 26619 | 1 |
| 196 | 28.4±5.7 | 1 |
| 197 | 29.5+/-8.4 | 1 |
| 198 | 29.66±5.6 | 1 |
| 199 | 298.40±37.77mosm | 1 |
| 200 | 2c18 | 1 |
| 201 | 2·52 | 1 |
| 202 | 3'-hc | 1 |
| 203 | 3,4,5-trimethoxybenzaldehyde | 1 |
| 204 | 3,4-didehydroretinol | 1 |
| 205 | 3,6-anhydrogalactose | 1 |
| 206 | 3,6-dichlorotetrazine | 1 |
| 207 | 3,821 | 1 |
| 208 | 3-amino-5-hydroxypyrazole | 1 |
| 209 | 3-bromo-4-hydroxy-2h-chromen-2-one | 1 |
| 210 | 3-ethoxy-4-hydroxybenzaldehyde | 1 |
| 211 | 3-indolinones | 1 |
| 212 | 3-indolyloxindoles | 1 |
| 213 | 3-methyleneoxindoles | 1 |
| 214 | 3-o-ac-l-rhamnose | 1 |
| 215 | 3-sulfenyl-indoles | 1 |
| 216 | 3.0/0.33 | 1 |
| 217 | 3.0log10cycles | 1 |
| 218 | 3.2+/-6 | 1 |
| 219 | 3.22±0.84 | 1 |
| 220 | 3.25°±2.04° | 1 |
| 221 | 3.30±1.10 | 1 |
| 222 | 3.37-fold | 1 |
| 223 | 3.38/10 | 1 |
| 224 | 3.6±4.1 | 1 |
| 225 | 3.76+/-6.25 | 1 |
| 226 | 3.7±1.3mm | 1 |
| 227 | 3.8±2.8 | 1 |
| 228 | 30-32.5°c | 1 |
| 229 | 30.31±75.85pg/ml | 1 |
| 230 | 300±100c/ml | 1 |
| 231 | 32.03±18.16 | 1 |
| 232 | 32.34±26.83min | 1 |
| 233 | 32.6h | 1 |
| 234 | 32.6±11.7 | 1 |
| 235 | 341,500 | 1 |
| 236 | 35-41°c | 1 |
| 237 | 35.6±3.7 | 1 |
| 238 | 36,791 | 1 |
| 239 | 36.1-49.1 | 1 |
| 240 | 36.2/35.3 | 1 |
| 241 | 38.45±3.3 | 1 |
| 242 | 38.4±11.8 | 1 |
| 243 | 38/57 | 1 |
| 244 | 391-401 | 1 |
| 245 | 3a1/2 | 1 |
| 246 | 3d-ef | 1 |
| 247 | 3·24 | 1 |
| 248 | 4,6'-diacetyl-3,3'-dmbp | 1 |
| 249 | 4-dimethylaminophenol | 1 |
| 250 | 4-phenylsemicarbazide | 1 |
| 251 | 4-steroid | 1 |
| 252 | 4.00±1.61 | 1 |
| 253 | 4.18±1.47 | 1 |
| 254 | 4.1g/g | 1 |
| 255 | 4.1±3.0 | 1 |
| 256 | 4.3±0.53 | 1 |
| 257 | 4.8/100,000 | 1 |
| 258 | 4.9±3.2 | 1 |
| 259 | 40,139€/qaly | 1 |
| 260 | 40,846 | 1 |
| 261 | 41.20 | 1 |
| 262 | 41.7+/-5.6 | 1 |
| 263 | 41.7±8.84 | 1 |
| 264 | 41/11 | 1 |
| 265 | 41:33:18 | 1 |
| 266 | 42:37:19 | 1 |
| 267 | 42±27.9 | 1 |
| 268 | 43.48±15.59 | 1 |
| 269 | 43.4±13.9 | 1 |
| 270 | 43.5±1.1 | 1 |
| 271 | 44,961 | 1 |
| 272 | 44.7/71.2 | 1 |
| 273 | 45.3° | 1 |
| 274 | 4518 | 1 |
| 275 | 46.13±94.70pg/ml | 1 |
| 276 | 485.1 | 1 |
| 277 | 49.5° | 1 |
| 278 | 49months | 1 |
| 279 | 4ebp | 1 |
| 280 | 5,6-positions | 1 |
| 281 | 5,623 | 1 |
| 282 | 5,929.6 | 1 |
| 283 | 5-fluorucacil | 1 |
| 284 | 5-heptyl-substituted | 1 |
| 285 | 5-methylterahydrofolate | 1 |
| 286 | 5.0db | 1 |
| 287 | 5.16±1.04mm | 1 |
| 288 | 5.1±13.4 | 1 |
| 289 | 5.46hz | 1 |
| 290 | 5.6/1,000 | 1 |
| 291 | 5.69±0.30 | 1 |
| 292 | 5.73months | 1 |
| 293 | 51.2+/-6 | 1 |
| 294 | 51.3±22.6 | 1 |
| 295 | 51.4+/-7 | 1 |
| 296 | 52.3±29 | 1 |
| 297 | 52±0.1gr | 1 |
| 298 | 53,601 | 1 |
| 299 | 5345 | 1 |
| 300 | 54,691 | 1 |
| 301 | 54.7±10.1 | 1 |
| 302 | 550±44.2minμg/ml | 1 |
| 303 | 552.86 | 1 |
| 304 | 57,964 | 1 |
| 305 | 57119 | 1 |
| 306 | 58.0±6.4s | 1 |
| 307 | 5898 | 1 |
| 308 | 59.4±9.7 | 1 |
| 309 | 5a1 | 1 |
| 310 | 6.0mm | 1 |
| 311 | 6.0±2.1° | 1 |
| 312 | 6.0±2.24 | 1 |
| 313 | 6.3±0.9 | 1 |
| 314 | 6.3±1.1 | 1 |
| 315 | 6.4days | 1 |
| 316 | 6/30/07 | 1 |
| 317 | 60,000/μl | 1 |
| 318 | 60.0months | 1 |
| 319 | 600mg/d | 1 |
| 320 | 61.1±6.4 | 1 |
| 321 | 642±153minμg/ml | 1 |
| 322 | 65,311-98,160 | 1 |
| 323 | 6503deltt | 1 |
| 324 | 65±31μm | 1 |
| 325 | 667/654 | 1 |
| 326 | 67,882 | 1 |
| 327 | 6894 | 1 |
| 328 | 7.38±0.19 | 1 |
| 329 | 7.54-fold | 1 |
| 330 | 7.60±7.46 | 1 |
| 331 | 7.94±0.41 | 1 |
| 332 | 7/09 | 1 |
| 333 | 7/187 | 1 |
| 334 | 71,103 | 1 |
| 335 | 76.5/56.2 | 1 |
| 336 | 76.75+/-0.4 | 1 |
| 337 | 79,310 | 1 |
| 338 | 79.1±28.1 | 1 |
| 339 | 8,251 | 1 |
| 340 | 8.19±1.79 | 1 |
| 341 | 8.20° | 1 |
| 342 | 8.57+/-1.08 | 1 |
| 343 | 8/200 | 1 |
| 344 | 82.0μm | 1 |
| 345 | 82/124 | 1 |
| 346 | 82days | 1 |
| 347 | 84-fold | 1 |
| 348 | 84/94 | 1 |
| 349 | 8549 | 1 |
| 350 | 8836 | 1 |
| 351 | 8t/8a | 1 |
| 352 | 9.35+/-0.3 | 1 |
| 353 | 9.4±1.3 | 1 |
| 354 | 9.77+/-6.51 | 1 |
| 355 | 9.8g/dl | 1 |
| 356 | 91,215 | 1 |
| 357 | 9163 | 1 |
| 358 | 95,236 | 1 |
| 359 | 9523 | 1 |
| 360 | 97microm | 1 |
| 361 | 9923 | 1 |
| 362 | a-23187 | 1 |
| 363 | a2rbs | 1 |
| 364 | abf2 | 1 |
| 365 | absent/negative | 1 |
| 366 | acidicaldus | 1 |
| 367 | adc-parameters | 1 |
| 368 | adenocarcinona | 1 |
| 369 | ades/adrs | 1 |
| 370 | adipoblasts | 1 |
| 371 | aerobiology | 1 |
| 372 | age-differences | 1 |
| 373 | aggregation-thrombolysis | 1 |
| 374 | ahr/xre | 1 |
| 375 | ala146 | 1 |
| 376 | alkaliphosphatase | 1 |
| 377 | alkyl-pahs | 1 |
| 378 | alkylideneoxindoles | 1 |
| 379 | allyltrimethylsilane | 1 |
| 380 | alpha-amino-nitrogen | 1 |
| 381 | alpha-amylase-activity | 1 |
| 382 | alterability | 1 |
| 383 | ambra-sinto | 1 |
| 384 | amiodarone-and | 1 |
| 385 | anapharm | 1 |
| 386 | angioscanner | 1 |
| 387 | anilinolactones | 1 |
| 388 | anti-progesterones | 2 |
| 389 | antiphlogistica | 1 |
| 390 | apergillosis | 1 |
| 391 | apple-pectin | 1 |
| 392 | arg108 | 1 |
| 393 | arg195 | 1 |
| 394 | arg214 | 1 |
| 395 | arg268 | 1 |
| 396 | argpyrimidine | 1 |
| 397 | artesunate+amodiaquine | 2 |
| 398 | arylpropiolamides | 1 |
| 399 | atelactasis | 1 |
| 400 | atg101 | 1 |
| 401 | atg12 | 1 |
| 402 | athsp90.5-7 | 1 |
| 403 | autophagic-responses | 1 |
| 404 | azalydes | 1 |
| 405 | azintamide | 1 |
| 406 | b/yamagata/16/88-like | 1 |
| 407 | balanoides | 1 |
| 408 | bapwv/cca-imt | 1 |
| 409 | bcells | 1 |
| 410 | bee×1.1×1.3-1.5 | 1 |
| 411 | bestent | 1 |
| 412 | beta-1,3-glucanase | 1 |
| 413 | beta-islets | 1 |
| 414 | betadm2 | 1 |
| 415 | blicks | 1 |
| 416 | bloc-ablation | 1 |
| 417 | blp-25 | 1 |
| 418 | bmd/markers/fractures | 1 |
| 419 | bolivians | 1 |
| 420 | bootsma | 1 |
| 421 | brachyteles | 1 |
| 422 | brainstem-cerebellum | 1 |
| 423 | brdu-labeling | 1 |
| 424 | bronchiectasies | 1 |
| 425 | bronchioloectasia | 1 |
| 426 | c-550t | 1 |
| 427 | c-gmp | 1 |
| 428 | c.3124_3133delagcaatatta | 1 |
| 429 | c.3897delt | 1 |
| 430 | c.5114_5117deltaaa | 1 |
| 431 | c.871-2_894del26 | 1 |
| 432 | c.887delc | 1 |
| 433 | c1603t | 1 |
| 434 | c2c3 | 1 |
| 435 | c695t-5 | 1 |
| 436 | ca/creatinine | 1 |
| 437 | cancer-killer | 1 |
| 438 | capitulated | 1 |
| 439 | carbamezepine | 1 |
| 440 | carers/friends | 1 |
| 441 | catabolism/anabolism | 1 |
| 442 | cbl-b | 1 |
| 443 | cc-2 | 1 |
| 444 | ccurred | 1 |
| 445 | cd320 | 1 |
| 446 | cd44/aldh1 | 1 |
| 447 | cdc48p | 1 |
| 448 | cedercholm | 1 |
| 449 | cefroxidine | 1 |
| 450 | cervicalis | 1 |
| 451 | chemo-protectors | 1 |
| 452 | chemorefractoriness | 1 |
| 453 | choelsterol | 1 |
| 454 | cholangiofibrosis | 1 |
| 455 | cinelli | 1 |
| 456 | cineol | 1 |
| 457 | cocos/bacilos | 1 |
| 458 | concentration-profiles | 1 |
| 459 | confided | 1 |
| 460 | conspecific-pecking | 1 |
| 461 | cooled/heated | 1 |
| 462 | coqs/ldl-c | 1 |
| 463 | cost/change | 1 |
| 464 | creedy | 1 |
| 465 | crem | 1 |
| 466 | crept | 1 |
| 467 | crt±cetuximab | 1 |
| 468 | crystallizes | 91 |
| 469 | ctz12 | 1 |
| 470 | culminated | 53 |
| 471 | cundy | 1 |
| 472 | cyfra21 | 1 |
| 473 | cytobacteriology | 1 |
| 474 | cytoheisn-2 | 1 |
| 475 | d165h | 1 |
| 476 | d=0.166 | 1 |
| 477 | dachshund-1 | 1 |
| 478 | daliy | 1 |
| 479 | darkness-and | 1 |
| 480 | dash-resulting | 1 |
| 481 | dbl5 | 1 |
| 482 | dbpcv | 1 |
| 483 | de-investment | 1 |
| 484 | deg/enacs | 1 |
| 485 | dentascan | 1 |
| 486 | deptomycin | 1 |
| 487 | desmethyl-clomipramine | 1 |
| 488 | desmins | 1 |
| 489 | devilish | 1 |
| 490 | dfps | 1 |
| 491 | diabetologists/endocrinologists | 1 |
| 492 | diastolic-dysfunction | 1 |
| 493 | dieter | 1 |
| 494 | diglucosides | 2 |
| 495 | dihydroxycholecalciferol | 1 |
| 496 | dipherelin | 1 |
| 497 | disrtict | 1 |
| 498 | disuria | 1 |
| 499 | dolasetron-differ | 1 |
| 500 | downgrafting | 1 |
| 501 | dqb1*03032 | 1 |
| 502 | drug-alone | 1 |
| 503 | dsbt-cbt-cwit | 1 |
| 504 | duerinckx | 1 |
| 505 | dwarf4 | 1 |
| 506 | dyskalemia | 1 |
| 507 | early-diastole | 1 |
| 508 | edendale | 1 |
| 509 | effectiveness¿ | 1 |
| 510 | egfp-14-3-3θ | 1 |
| 511 | encourageable | 1 |
| 512 | entente | 1 |
| 513 | enteronitis | 1 |
| 514 | enynes | 1 |
| 515 | epidermal-growth-factor-concentrations | 1 |
| 516 | euro6020 | 1 |
| 517 | euverted | 1 |
| 518 | ex-pensive | 1 |
| 519 | exacerbative | 1 |
| 520 | exsudativa | 1 |
| 521 | f3'h-activity | 1 |
| 522 | fahrzeugtechnik | 1 |
| 523 | fatten | 1 |
| 524 | fensham | 1 |
| 525 | fibroblast-based | 1 |
| 526 | fibropapillomas | 1 |
| 527 | fkhrl1 | 1 |
| 528 | folfox-b | 1 |
| 529 | foodways | 1 |
| 530 | fraxinea | 1 |
| 531 | freeze-concentrate | 1 |
| 532 | friedrichschafen | 1 |
| 533 | ft-nmr | 1 |
| 534 | fufox | 1 |
| 535 | fv1x | 1 |
| 536 | g87 | 1 |
| 537 | gabbe | 1 |
| 538 | galacturonate | 1 |
| 539 | gases/fumes | 1 |
| 540 | gender-weights | 1 |
| 541 | gene-scaffolds | 1 |
| 542 | gezondheid | 1 |
| 543 | gh14-3-3h | 1 |
| 544 | gh90 | 1 |
| 545 | glu149 | 1 |
| 546 | gluconeogenesis/glycolysis | 1 |
| 547 | glucosine | 1 |
| 548 | gly128→asp | 1 |
| 549 | glycyltryptophanylglycylglycine | 1 |
| 550 | goldis | 1 |
| 551 | gpmk1 | 1 |
| 552 | gps'reports | 1 |
| 553 | grizzard | 1 |
| 554 | group/attrition | 1 |
| 555 | gtl2-2 | 1 |
| 556 | haptoglobulin | 1 |
| 557 | healthy-controls | 1 |
| 558 | heme-chromophores | 1 |
| 559 | hemianopsia | 1 |
| 560 | hemolysis-and | 1 |
| 561 | hendrickse | 1 |
| 562 | hepatosplenomegly | 1 |
| 563 | his248 | 1 |
| 564 | hisaralan | 1 |
| 565 | hnrnp-k | 1 |
| 566 | hot-flushes | 1 |
| 567 | hpv/hiv | 1 |
| 568 | hsfc2 | 1 |
| 569 | hsl-mrnas | 1 |
| 570 | hydroxo-bridges | 1 |
| 571 | hyper-leukocytes | 1 |
| 572 | hyper-lipidemia | 1 |
| 573 | hyperfibrogenemia | 1 |
| 574 | hyperlipogensisi | 1 |
| 575 | hyperlipoidemia | 1 |
| 576 | hypoadiponectin | 1 |
| 577 | h₂wo₄ | 1 |
| 578 | i-troponin | 1 |
| 579 | ibotenate | 1 |
| 580 | idmtx | 1 |
| 581 | igfs/igfbps | 1 |
| 582 | ikji | 1 |
| 583 | il-0.05 | 1 |
| 584 | il-8-values | 1 |
| 585 | immaging | 1 |
| 586 | implimented | 1 |
| 587 | inductest | 1 |
| 588 | inter-acting | 1 |
| 589 | interleukin-lβ | 1 |
| 590 | interleukin‑6 | 1 |
| 591 | interpenetrate | 1 |
| 592 | intervente | 1 |
| 593 | interventi | 1 |
| 594 | intra-abomasally | 1 |
| 595 | intra-canalicular | 1 |
| 596 | intrusion-distress | 1 |
| 597 | iodid | 1 |
| 598 | irctimbalance | 1 |
| 599 | irreplaceability | 1 |
| 600 | irreproductible | 1 |
| 601 | isheri-igando | 1 |
| 602 | isting | 2 |
| 603 | jin-ye | 1 |
| 604 | kainantu | 2 |
| 605 | kawangware | 1 |
| 606 | kers | 1 |
| 607 | knights | 1 |
| 608 | knowhow | 1 |
| 609 | kucing | 1 |
| 610 | l-b6 | 1 |
| 611 | lat3 | 1 |
| 612 | leucyl-histidylhydrazide | 1 |
| 613 | levatroplasty | 1 |
| 614 | lh-responsiveness | 1 |
| 615 | li-may | 1 |
| 616 | lieing | 1 |
| 617 | light-reaction | 1 |
| 618 | lipoperoxidase | 1 |
| 619 | lizhong-tang | 1 |
| 620 | lns/min | 2 |
| 621 | low-dose-heparin | 1 |
| 622 | low-likers | 1 |
| 623 | lpin1-β | 1 |
| 624 | lymphadentis | 1 |
| 625 | lys-240 | 1 |
| 626 | lys51/56/53 | 1 |
| 627 | m-helices | 1 |
| 628 | m3c | 1 |
| 629 | maccleod | 1 |
| 630 | madias | 1 |
| 631 | maibi | 1 |
| 632 | malignoma | 1 |
| 633 | maltodextrin-glucose | 1 |
| 634 | mapk/p38 | 1 |
| 635 | mate-2k | 1 |
| 636 | mathias | 1 |
| 637 | mazury | 1 |
| 638 | mckhann | 1 |
| 639 | meldoniya | 1 |
| 640 | membrane-specifically | 1 |
| 641 | meopa | 1 |
| 642 | meta-analyses.2 | 1 |
| 643 | metallisation | 1 |
| 644 | metamaks | 1 |
| 645 | mglur-signaling | 1 |
| 646 | microholes | 1 |
| 647 | micronucleation | 1 |
| 648 | microparticulates | 1 |
| 649 | microperforations | 1 |
| 650 | middle-methylation | 1 |
| 651 | mihjam | 2 |
| 652 | mineralocorticoid-receptor-antagonists | 1 |
| 653 | mir-199 | 1 |
| 654 | mir-486 | 1 |
| 655 | misgrated | 1 |
| 656 | ml/min/l | 2 |
| 657 | mnf3 | 1 |
| 658 | mnur | 1 |
| 659 | monosialoganglioside | 1 |
| 660 | mother's/mother | 1 |
| 661 | mptms | 1 |
| 662 | msrc | 1 |
| 663 | mtx-groups | 1 |
| 664 | muconolactone | 1 |
| 665 | multi-leaf-collimators | 1 |
| 666 | multiplexer/demultiplexer | 1 |
| 667 | murad® | 1 |
| 668 | musculoskeletal-based | 1 |
| 669 | mx97-8147 | 1 |
| 670 | mycoplasmas-positive | 1 |
| 671 | myeloperoxidation | 1 |
| 672 | myofibroproliferation | 1 |
| 673 | n-alkylisatins | 1 |
| 674 | n512 | 1 |
| 675 | n=2188 | 1 |
| 676 | nagana | 1 |
| 677 | nanoaggregates | 1 |
| 678 | nanoencapsuted | 1 |
| 679 | nc-n | 1 |
| 680 | necrosis/fibrosis | 1 |
| 681 | neosporosis | 1 |
| 682 | nerve/plexus | 1 |
| 683 | neurecover-sa | 1 |
| 684 | nfκb-activation | 1 |
| 685 | nh4+-n/l | 2 |
| 686 | nifuroxime | 1 |
| 687 | nitrite-anions | 1 |
| 688 | no-shunts | 1 |
| 689 | nodvocain | 1 |
| 690 | noise/oversensing | 1 |
| 691 | non-access-related | 1 |
| 692 | non-acquirers | 1 |
| 693 | non-coercively | 1 |
| 694 | non-malignancy | 1 |
| 695 | non-rejection | 1 |
| 696 | non-ring-wearers | 1 |
| 697 | non-supplementation | 1 |
| 698 | nonring-wearers | 1 |
| 699 | nonself-antigens | 1 |
| 700 | nonsmokers-participated | 1 |
| 701 | nonstationarities | 1 |
| 702 | numbness/tingling | 1 |
| 703 | o-h12 | 1 |
| 704 | oatp1b3/slco1b3 | 1 |
| 705 | oder | 2 |
| 706 | of/kinks | 1 |
| 707 | ofprp | 1 |
| 708 | ofstatins | 1 |
| 709 | omega-c | 1 |
| 710 | ona-ma | 1 |
| 711 | oogonia | 1 |
| 712 | opitz | 1 |
| 713 | oprh | 1 |
| 714 | osfd-gogat | 3 |
| 715 | osgdh3 | 1 |
| 716 | oshsfc1b | 1 |
| 717 | oshsp18.0 | 1 |
| 718 | ossos1 | 1 |
| 719 | otorrhagia | 1 |
| 720 | outcome- | 1 |
| 721 | over-eruption | 1 |
| 722 | over-exuberance | 1 |
| 723 | overall-mortality | 1 |
| 724 | overwintered | 2 |
| 725 | p.e4181k | 1 |
| 726 | p.e767fs | 1 |
| 727 | p.q201h | 1 |
| 728 | p.ser615leu | 1 |
| 729 | p.v600k | 1 |
| 730 | p97.5 | 1 |
| 731 | pacemaker-induced | 1 |
| 732 | pakt1 | 1 |
| 733 | pank4 | 1 |
| 734 | paribus | 1 |
| 735 | participates | 249 |
| 736 | pastaza | 1 |
| 737 | pb-rb | 1 |
| 738 | pc-kus | 1 |
| 739 | pecfent® | 1 |
| 740 | peer-moderation | 1 |
| 741 | pellinos | 1 |
| 742 | penicillin-v | 1 |
| 743 | perturbances | 1 |
| 744 | pharmaco-electroencephalography | 1 |
| 745 | phase-changes | 1 |
| 746 | phe-phe-nh2 | 1 |
| 747 | phe55 | 1 |
| 748 | phenyle-phrine | 1 |
| 749 | phenylethyl-itc | 1 |
| 750 | phenylyalanine | 1 |
| 751 | phosphatemic | 1 |
| 752 | phospho-syk | 1 |
| 753 | phosphorylated-cjun | 1 |
| 754 | phosphorylated-s6 | 1 |
| 755 | pieber | 1 |
| 756 | pilot-implementation | 1 |
| 757 | pin-stripping | 1 |
| 758 | planterflexors | 1 |
| 759 | plasmacytogenesis | 1 |
| 760 | plausibility.the | 1 |
| 761 | plethsmography | 1 |
| 762 | polymagma | 1 |
| 763 | post-aes | 1 |
| 764 | post-ecls | 1 |
| 765 | post-egfr | 1 |
| 766 | post-wbv | 1 |
| 767 | post-whisper | 1 |
| 768 | pound1,458,268,104 | 1 |
| 769 | ppar-α-γ | 1 |
| 770 | pphcl2 | 2 |
| 771 | preparation-transplantation | 1 |
| 772 | pretarsus | 1 |
| 773 | pro-mmp-13 | 1 |
| 774 | procinetics | 1 |
| 775 | procitis | 1 |
| 776 | programs-particularly | 1 |
| 777 | proteinuira | 1 |
| 778 | provements | 1 |
| 779 | pseudomonadales | 1 |
| 780 | pulmonary-pleurostaphylococci | 1 |
| 781 | purpald® | 1 |
| 782 | pvwy | 1 |
| 783 | quadruparesis | 1 |
| 784 | quasi-3.36-level | 1 |
| 785 | r1628p | 1 |
| 786 | r254 | 2 |
| 787 | r73 | 1 |
| 788 | railings | 1 |
| 789 | re-enrolling | 1 |
| 790 | re-packed | 1 |
| 791 | re-recorded | 1 |
| 792 | reality-oriented | 1 |
| 793 | reduced/eliminated | 1 |
| 794 | reengulfment | 1 |
| 795 | reenrolling | 1 |
| 796 | rehydrolyzation | 1 |
| 797 | repeat-hltx | 1 |
| 798 | resisting-pain | 1 |
| 799 | resorbs | 1 |
| 800 | responsibilities-and | 1 |
| 801 | resulted | 16,468 |
| 802 | retranslocated | 1 |
| 803 | retroplastic | 1 |
| 804 | retrospectivity | 1 |
| 805 | revengeful | 1 |
| 806 | rhli | 1 |
| 807 | rice/pasta | 1 |
| 808 | rietvlei | 2 |
| 809 | rmopr | 1 |
| 810 | ro-115-1240 | 1 |
| 811 | rollerblades | 1 |
| 812 | rouges | 1 |
| 813 | rowed | 1 |
| 814 | rs1063539 | 1 |
| 815 | rs1176713-gg | 1 |
| 816 | rs1517618 | 1 |
| 817 | rs1569480 | 1 |
| 818 | rs16944 | 1 |
| 819 | rs17129561 | 1 |
| 820 | rs17614942-ac | 1 |
| 821 | rs2293286 | 1 |
| 822 | rs3743527 | 1 |
| 823 | rs3820185 | 1 |
| 824 | rs3887412 | 1 |
| 825 | rs4525 | 1 |
| 826 | rs6795970 | 1 |
| 827 | rs7801617 | 1 |
| 828 | rs9402349 | 1 |
| 829 | rs9458172 | 1 |
| 830 | rs9902941 | 1 |
| 831 | rsus | 1 |
| 832 | rtp4 | 1 |
| 833 | rubiales | 1 |
| 834 | rv-sr | 1 |
| 835 | s9-enhancing | 1 |
| 836 | sanou | 1 |
| 837 | sc-40230 | 1 |
| 838 | scientists/bhp | 1 |
| 839 | sdldl/lhdl | 1 |
| 840 | secretorum | 1 |
| 841 | selectiveness | 1 |
| 842 | self-representation | 1 |
| 843 | senataxin | 1 |
| 844 | ser-171 | 1 |
| 845 | ser353 | 1 |
| 846 | ser65cys/wt | 1 |
| 847 | ser80-to-ile | 1 |
| 848 | sif4 | 1 |
| 849 | simvasatin | 1 |
| 850 | simvastatin-differ | 1 |
| 851 | simvastatin-used | 1 |
| 852 | sirt7 | 1 |
| 853 | sitcom | 1 |
| 854 | sociale | 1 |
| 855 | solidus | 1 |
| 856 | sparcity | 1 |
| 857 | spectially | 1 |
| 858 | sreepur | 1 |
| 859 | srlong | 1 |
| 860 | st-elevations | 1 |
| 861 | stat-4 | 1 |
| 862 | stillbirths/abortions | 2 |
| 863 | sub-chorionitis | 1 |
| 864 | succeeds | 15 |
| 865 | sucesso | 1 |
| 866 | sult1e1 | 2 |
| 867 | superbroadly | 1 |
| 868 | swertiamarian | 1 |
| 869 | symptom-generating | 1 |
| 870 | symtomps | 1 |
| 871 | synaptotoxicity | 1 |
| 872 | syphillis | 1 |
| 873 | t219a | 1 |
| 874 | t80a-a90g | 1 |
| 875 | tag-positioning | 1 |
| 876 | talukas | 1 |
| 877 | texturizer | 1 |
| 878 | tgf-βr1 | 1 |
| 879 | tgf-‑β1 | 1 |
| 880 | thermostresses | 1 |
| 881 | thr-603 | 1 |
| 882 | thr105ile | 1 |
| 883 | time-to-detection | 2 |
| 884 | tips-ebx* | 1 |
| 885 | tn6222 | 1 |
| 886 | tnpo | 1 |
| 887 | tone-sweeps | 1 |
| 888 | tongnaab | 1 |
| 889 | toparticipate | 1 |
| 890 | trans-2-hexenal | 1 |
| 891 | transformation-metabolism | 1 |
| 892 | treg-cells | 1 |
| 893 | trerapy | 1 |
| 894 | triangulatus | 1 |
| 895 | triatomids | 1 |
| 896 | trivette | 1 |
| 897 | trp283 | 1 |
| 898 | tsh-level | 1 |
| 899 | ttatg8s | 1 |
| 900 | tulokas | 1 |
| 901 | tuszyński | 1 |
| 902 | tyr-105 | 1 |
| 903 | tyr1173 | 1 |
| 904 | tyr224 | 1 |
| 905 | u2os/mtx300 | 1 |
| 906 | ubiaja | 1 |
| 907 | ufh/vkas | 1 |
| 908 | ugt1a9/2b7 | 1 |
| 909 | ugym2 | 2 |
| 910 | ul47 | 1 |
| 911 | ultrastability | 1 |
| 912 | uncoil | 1 |
| 913 | under-achieve | 1 |
| 914 | underachieving | 1 |
| 915 | undercontrolled | 1 |
| 916 | underprovided | 1 |
| 917 | uniocularly | 1 |
| 918 | unsaturations | 1 |
| 919 | up-stage | 1 |
| 920 | urea-nitrogen | 1 |
| 921 | uretero-ileal | 1 |
| 922 | urethritis-especially | 1 |
| 923 | uroprotection | 1 |
| 924 | urosepsis/death | 1 |
| 925 | ushered | 14 |
| 926 | uv-susceptibility | 1 |
| 927 | vad-volunteers | 1 |
| 928 | vegf-d/vegfr-3 | 1 |
| 929 | vegfr2-promoters | 1 |
| 930 | verteporfin-pdt | 1 |
| 931 | viferon | 1 |
| 932 | vigabatrine | 1 |
| 933 | violet-light | 1 |
| 934 | volatisation | 1 |
| 935 | vortexing | 1 |
| 936 | vs.vancomycin | 1 |
| 937 | waitresses | 1 |
| 938 | wenereology | 1 |
| 939 | whang | 1 |
| 940 | wobbles | 1 |
| 941 | wobbling | 1 |
| 942 | xilooligosaccharides | 1 |
| 943 | y654-beta-catenin | 1 |
| 944 | yoyoirt2 | 1 |
| 945 | zareba | 1 |
| 946 | zexanthin | 1 |
| 947 | ~2.7-fold | 1 |
| 948 | ~27-fold | 1 |
| 949 | ~410 | 1 |
| 950 | ~70-fold | 1 |
| 951 | £10,148/qaly | 1 |
| 952 | £1560.21 | 1 |
| 953 | £242.20 | 1 |
| 954 | £496,556 | 1 |
| 955 | ¥41 | 1 |
| 956 | çatağıl | 1 |
| 957 | β-esterases | 1 |
| 958 | βcys241 | 1 |
| 959 | δamylin30/δglucose30 | 1 |
| 960 | δfm-ul | 1 |
| 961 | δsto2 | 1 |
| 962 | ε-lactones | 1 |
| 963 | €/year | 1 |
| 964 | €113 | 1 |
| 965 | €115 | 1 |
| 966 | €16,438/qaly | 1 |
| 967 | €2,488 | 1 |
| 968 | €27,885 | 1 |
| 969 | €28 | 1 |
| 970 | €375 | 1 |
| 971 | €3830/woman | 1 |
| 972 | €4,828 | 1 |
| 973 | €4576 | 1 |
| 974 | €6857 | 1 |
| 975 | ∼135-fold | 1 |
| 976 | ≤20/50 | 1 |
| 977 | ≥67° | 1 |
| 978 | ≥90cm | 1 |
| 1 | tips-ebx* | 1 |
| 2 | outcome- | 1 |
| 3 | 4.1±3.0 | 1 |
| 4 | 20,131.3-23,574.0 | 1 |
| 5 | -9.8±6.0 | 1 |
| 6 | oshsp18.0 | 1 |
| 7 | 2.77±1.00 | 1 |
| 8 | 110/100,000 | 1 |
| 9 | 0.4/100,000 | 1 |
| 10 | 4.8/100,000 | 1 |
| 11 | 138/100,000 | 1 |
| 12 | 5.6/1,000 | 1 |
| 13 | 1/14,000 | 1 |
| 14 | 2.3/1000 | 1 |
| 15 | 12.4/1000 | 1 |
| 16 | 183.65/1000 | 1 |
| 17 | 160-180/90-100 | 1 |
| 18 | 1:2,200 | 1 |
| 19 | 8/200 | 1 |
| 20 | u2os/mtx300 | 1 |
| 21 | 1/6400 | 1 |
| 22 | 341,500 | 1 |
| 23 | 2300-0700 | 1 |
| 24 | 0.38±0.10 | 1 |
| 25 | 3.30±1.10 | 1 |
| 26 | 3.38/10 | 1 |
| 27 | 79,310 | 1 |
| 28 | ~410 | 1 |
| 29 | 41.20 | 1 |
| 30 | £242.20 | 1 |
| 31 | euro6020 | 1 |
| 32 | cd320 | 1 |
| 33 | 0.70:0.30 | 1 |
| 34 | 5.69±0.30 | 1 |
| 35 | sc-40230 | 1 |
| 36 | 17,730 | 1 |
| 37 | δamylin30/δglucose30 | 1 |
| 38 | lys-240 | 1 |
| 39 | ro-115-1240 | 1 |
| 40 | ≤20/50 | 1 |
| 41 | 174/250 | 1 |
| 42 | 65,311-98,160 | 1 |
| 43 | rs6795970 | 1 |
| 44 | 1.24+/-0.80 | 1 |
| 45 | rs1569480 | 1 |
| 46 | gh90 | 1 |
| 47 | dachshund-1 | 1 |
| 48 | 54.7±10.1 | 1 |
| 49 | 0.9:0.1 | 1 |
| 50 | 24,081.1 | 1 |
| 51 | -4.1±1.1 | 1 |
| 52 | 6.3±1.1 | 1 |
| 53 | 1.43±1.1 | 1 |
| 54 | 43.5±1.1 | 1 |
| 55 | 18.5±4.1 | 1 |
| 56 | 3.6±4.1 | 1 |
| 57 | 485.1 | 1 |
| 58 | -10.7±5.1 | 1 |
| 59 | 12.9+/-6.1 | 1 |
| 60 | 79.1±28.1 | 1 |
| 61 | 36.1-49.1 | 1 |
| 62 | atg101 | 1 |
| 63 | 391-401 | 1 |
| 64 | 53,601 | 1 |
| 65 | -0.48±0.11 | 1 |
| 66 | 2.93±1.11 | 1 |
| 67 | 41/11 | 1 |
| 68 | 26.8±11 | 1 |
| 69 | £1560.21 | 1 |
| 70 | 3,821 | 1 |
| 71 | cyfra21 | 1 |
| 72 | 13q21 | 1 |
| 73 | 244+/-31 | 1 |
| 74 | -0.15/-0.31 | 1 |
| 75 | 2002/3/31 | 1 |
| 76 | 7.94±0.41 | 1 |
| 77 | βcys241 | 1 |
| 78 | rs9902941 | 1 |
| 79 | ¥41 | 1 |
| 80 | 0.91±0.51 | 1 |
| 81 | 1.09â±0.51 | 1 |
| 82 | 9.77+/-6.51 | 1 |
| 83 | 8,251 | 1 |
| 84 | 4.00±1.61 | 1 |
| 85 | rs17129561 | 1 |
| 86 | 44,961 | 1 |
| 87 | 0.41+/-0.71 | 1 |
| 88 | ser-171 | 1 |
| 89 | 12,471 | 1 |
| 90 | 0.80±0.81 | 1 |
| 91 | 54,691 | 1 |
| 92 | 36,791 | 1 |
| 93 | 1.88:1 | 1 |
| 94 | 5a1 | 1 |
| 95 | sult1e1 | 2 |
| 96 | cd44/aldh1 | 1 |
| 97 | gpmk1 | 1 |
| 98 | fkhrl1 | 1 |
| 99 | tgf-βr1 | 1 |
| 100 | ossos1 | 1 |
| 101 | pakt1 | 1 |
| 102 | tgf-‑β1 | 1 |
| 103 | gtl2-2 | 1 |
| 104 | cc-2 | 1 |
| 105 | cytoheisn-2 | 1 |
| 106 | 0.68+/-0.2 | 1 |
| 107 | 0.26±0.2 | 1 |
| 108 | 44.7/71.2 | 1 |
| 109 | 4.9±3.2 | 1 |
| 110 | 76.5/56.2 | 1 |
| 111 | -5.6±9.2 | 1 |
| 112 | meta-analyses.2 | 1 |
| 113 | 3a1/2 | 1 |
| 114 | rs3887412 | 1 |
| 115 | n512 | 1 |
| 116 | atg12 | 1 |
| 117 | o-h12 | 1 |
| 118 | ctz12 | 1 |
| 119 | 0.0417±0.022 | 1 |
| 120 | tn6222 | 1 |
| 121 | dqb1*03032 | 1 |
| 122 | 222,732 | 1 |
| 123 | 0.13+/-0.42 | 1 |
| 124 | -14242 | 1 |
| 125 | 2·52 | 1 |
| 126 | 113.63+/-12.62 | 1 |
| 127 | rs9458172 | 1 |
| 128 | 67,882 | 1 |
| 129 | 11.18+/-7.92 | 1 |
| 130 | hsfc2 | 1 |
| 131 | abf2 | 1 |
| 132 | phe-phe-nh2 | 1 |
| 133 | pphcl2 | 2 |
| 134 | betadm2 | 1 |
| 135 | ugym2 | 2 |
| 136 | δsto2 | 1 |
| 137 | yoyoirt2 | 1 |
| 138 | vegf-d/vegfr-3 | 1 |
| 139 | 0.72+/-0.3 | 1 |
| 140 | 9.35+/-0.3 | 1 |
| 141 | 0.5+/-0.2-0.6+/-0.3 | 1 |
| 142 | 1.2±1.3 | 1 |
| 143 | 9.4±1.3 | 1 |
| 144 | 12.6±1.3 | 1 |
| 145 | 0.9±1.3 | 1 |
| 146 | 38.45±3.3 | 1 |
| 147 | 36.2/35.3 | 1 |
| 148 | 71,103 | 1 |
| 149 | 114/103 | 1 |
| 150 | -14103 | 1 |
| 151 | thr-603 | 1 |
| 152 | pro-mmp-13 | 1 |
| 153 | 2.99-7.13 | 1 |
| 154 | €113 | 1 |
| 155 | 9523 | 1 |
| 156 | 5,623 | 1 |
| 157 | 169,823 | 1 |
| 158 | 9923 | 1 |
| 159 | 3.0/0.33 | 1 |
| 160 | 12.97±4.33 | 1 |
| 161 | 0.97-2.43 | 1 |
| 162 | 4.3±0.53 | 1 |
| 163 | lys51/56/53 | 1 |
| 164 | ser353 | 1 |
| 165 | 9163 | 1 |
| 166 | 128/73 | 1 |
| 167 | tyr1173 | 1 |
| 168 | r73 | 1 |
| 169 | trp283 | 1 |
| 170 | oatp1b3/slco1b3 | 1 |
| 171 | c2c3 | 1 |
| 172 | mnf3 | 1 |
| 173 | osgdh3 | 1 |
| 174 | lat3 | 1 |
| 175 | stat-4 | 1 |
| 176 | 76.75+/-0.4 | 1 |
| 177 | 23.1±21.4 | 1 |
| 178 | 5.1±13.4 | 1 |
| 179 | 61.1±6.4 | 1 |
| 180 | 29.5+/-8.4 | 1 |
| 181 | 2.84+/-4.04 | 1 |
| 182 | pound1,458,268,104 | 1 |
| 183 | 20/114 | 1 |
| 184 | arg214 | 1 |
| 185 | 0.45+/-0.24 | 1 |
| 186 | 6.0±2.24 | 1 |
| 187 | 82/124 | 1 |
| 188 | tyr224 | 1 |
| 189 | 3·24 | 1 |
| 190 | 0.69+/-0.34 | 1 |
| 191 | 2.02â±0.44 | 1 |
| 192 | 1:6844 | 1 |
| 193 | rs16944 | 1 |
| 194 | 20,254 | 1 |
| 195 | r254 | 2 |
| 196 | 667/654 | 1 |
| 197 | 210/1564 | 1 |
| 198 | 57,964 | 1 |
| 199 | 158-174 | 1 |
| 200 | 3.22±0.84 | 1 |
| 201 | 0.43±0.84 | 1 |
| 202 | 41.7±8.84 | 1 |
| 203 | 84/94 | 1 |
| 204 | 6894 | 1 |
| 205 | sif4 | 1 |
| 206 | dwarf4 | 1 |
| 207 | pank4 | 1 |
| 208 | rtp4 | 1 |
| 209 | c695t-5 | 1 |
| 210 | bee×1.1×1.3-1.5 | 1 |
| 211 | 2611.5 | 1 |
| 212 | 0.4±1.5 | 1 |
| 213 | 14.5±1.5 | 1 |
| 214 | 1.8±1.5 | 1 |
| 215 | p97.5 | 1 |
| 216 | 104.3±19.5 | 1 |
| 217 | il-0.05 | 1 |
| 218 | tyr-105 | 1 |
| 219 | 0.85/0.15 | 1 |
| 220 | €115 | 1 |
| 221 | 91,215 | 1 |
| 222 | 137,815 | 1 |
| 223 | blp-25 | 1 |
| 224 | 3.76+/-6.25 | 1 |
| 225 | rs4525 | 1 |
| 226 | 132/135 | 1 |
| 227 | 0.73±0.45 | 1 |
| 228 | 2.01+/-5.45 | 1 |
| 229 | 5345 | 1 |
| 230 | 247,755 | 1 |
| 231 | phe55 | 1 |
| 232 | 0.7365 | 1 |
| 233 | €375 | 1 |
| 234 | rs3820185 | 1 |
| 235 | €27,885 | 1 |
| 236 | arg195 | 1 |
| 237 | dbl5 | 1 |
| 238 | 51.2+/-6 | 1 |
| 239 | 3.2+/-6 | 1 |
| 240 | 51.3±22.6 | 1 |
| 241 | 14.93±2.6 | 1 |
| 242 | -4.2±4.6 | 1 |
| 243 | 41.7+/-5.6 | 1 |
| 244 | 2.4-5.6 | 1 |
| 245 | 29.66±5.6 | 1 |
| 246 | 101.9-128.6 | 1 |
| 247 | 5,929.6 | 1 |
| 248 | 0.13±0.16 | 1 |
| 249 | 112.16 | 1 |
| 250 | 32.03±18.16 | 1 |
| 251 | -0.916 | 1 |
| 252 | c.871-2_894del26 | 1 |
| 253 | 95,236 | 1 |
| 254 | 8836 | 1 |
| 255 | 7.60±7.46 | 1 |
| 256 | ala146 | 1 |
| 257 | 40,846 | 1 |
| 258 | £496,556 | 1 |
| 259 | d=0.166 | 1 |
| 260 | 125,866 | 1 |
| 261 | 167/476 | 1 |
| 262 | €4576 | 1 |
| 263 | 1.86±0.86 | 1 |
| 264 | 552.86 | 1 |
| 265 | rs2293286 | 1 |
| 266 | mir-486 | 1 |
| 267 | l-b6 | 1 |
| 268 | phosphorylated-s6 | 1 |
| 269 | interleukin‑6 | 1 |
| 270 | 51.4+/-7 | 1 |
| 271 | athsp90.5-7 | 1 |
| 272 | 32.6±11.7 | 1 |
| 273 | 35.6±3.7 | 1 |
| 274 | 28.4±5.7 | 1 |
| 275 | 15.7±6.7 | 1 |
| 276 | 12447.7 | 1 |
| 277 | 59.4±9.7 | 1 |
| 278 | 6/30/07 | 1 |
| 279 | 10,507 | 1 |
| 280 | rs7801617 | 1 |
| 281 | rs3743527 | 1 |
| 282 | 11/237 | 1 |
| 283 | 4.18±1.47 | 1 |
| 284 | mx97-8147 | 1 |
| 285 | 0.9447 | 1 |
| 286 | ul47 | 1 |
| 287 | 38/57 | 1 |
| 288 | 19,157 | 1 |
| 289 | 1:8657 | 1 |
| 290 | €6857 | 1 |
| 291 | 2.18±0.77 | 1 |
| 292 | 7/187 | 1 |
| 293 | a-23187 | 1 |
| 294 | g87 | 1 |
| 295 | '97 | 1 |
| 296 | 1.6±0.97 | 1 |
| 297 | ugt1a9/2b7 | 1 |
| 298 | sirt7 | 1 |
| 299 | 38.4±11.8 | 1 |
| 300 | 3.8±2.8 | 1 |
| 301 | 14.9+/-9.8 | 1 |
| 302 | 8.57+/-1.08 | 1 |
| 303 | arg108 | 1 |
| 304 | 1:118 | 1 |
| 305 | 16,318 | 1 |
| 306 | 4518 | 1 |
| 307 | rs1517618 | 1 |
| 308 | 41:33:18 | 1 |
| 309 | 2c18 | 1 |
| 310 | 120,428 | 1 |
| 311 | €4,828 | 1 |
| 312 | €28 | 1 |
| 313 | 2270.5±134.38 | 1 |
| 314 | mapk/p38 | 1 |
| 315 | his248 | 1 |
| 316 | 0.38+/-0.58 | 1 |
| 317 | arg268 | 1 |
| 318 | 23,878 | 1 |
| 319 | 26.62±4.88 | 1 |
| 320 | n=2188 | 1 |
| 321 | €2,488 | 1 |
| 322 | 1.2±0.7888 | 1 |
| 323 | 5898 | 1 |
| 324 | 6.3±0.9 | 1 |
| 325 | 43.4±13.9 | 1 |
| 326 | 16.9+/-6.9 | 1 |
| 327 | 42±27.9 | 1 |
| 328 | 0.671+/-0.09 | 1 |
| 329 | 0.733+/-0.09 | 1 |
| 330 | 7/09 | 1 |
| 331 | 7.38±0.19 | 1 |
| 332 | 11.14+/-1.19 | 1 |
| 333 | 11.4±1.19 | 1 |
| 334 | 57119 | 1 |
| 335 | 26619 | 1 |
| 336 | 42:37:19 | 1 |
| 337 | 13/129 | 1 |
| 338 | 52.3±29 | 1 |
| 339 | rs1063539 | 1 |
| 340 | glu149 | 1 |
| 341 | rs9402349 | 1 |
| 342 | 8549 | 1 |
| 343 | 05:49 | 1 |
| 344 | 0.93â±0.59 | 1 |
| 345 | 43.48±15.59 | 1 |
| 346 | 10,159 | 1 |
| 347 | 0.71-5.69 | 1 |
| 348 | 2.15±0.79 | 1 |
| 349 | 8.19±1.79 | 1 |
| 350 | mir-199 | 1 |
| 351 | +ifn-a | 1 |
| 352 | 8t/8a | 1 |
| 353 | t219a | 1 |
| 354 | c.5114_5117deltaaa | 1 |
| 355 | zareba | 1 |
| 356 | 2,5-dhba | 1 |
| 357 | antiphlogistica | 1 |
| 358 | fraxinea | 1 |
| 359 | otorrhagia | 1 |
| 360 | hyperlipoidemia | 1 |
| 361 | hyper-lipidemia | 1 |
| 362 | dyskalemia | 1 |
| 363 | hyperfibrogenemia | 1 |
| 364 | oogonia | 1 |
| 365 | disuria | 1 |
| 366 | bronchioloectasia | 1 |
| 367 | hemianopsia | 1 |
| 368 | ubiaja | 1 |
| 369 | ona-ma | 1 |
| 370 | polymagma | 1 |
| 371 | malignoma | 1 |
| 372 | bootsma | 1 |
| 373 | nagana | 1 |
| 374 | adenocarcinona | 1 |
| 375 | 16:0-coa | 1 |
| 376 | meopa | 1 |
| 377 | proteinuira | 1 |
| 378 | neurecover-sa | 1 |
| 379 | rice/pasta | 1 |
| 380 | c.3124_3133delagcaatatta | 1 |
| 381 | exsudativa | 1 |
| 382 | 1yxa | 1 |
| 383 | meldoniya | 1 |
| 384 | pastaza | 1 |
| 385 | cbl-b | 1 |
| 386 | folfox-b | 1 |
| 387 | oshsfc1b | 1 |
| 388 | tongnaab | 1 |
| 389 | crt±cetuximab | 1 |
| 390 | 5.0db | 1 |
| 391 | pb-rb | 1 |
| 392 | omega-c | 1 |
| 393 | coqs/ldl-c | 1 |
| 394 | m3c | 1 |
| 395 | rs17614942-ac | 1 |
| 396 | 3'-hc | 1 |
| 397 | phosphatemic | 1 |
| 398 | retroplastic | 1 |
| 399 | c.887delc | 1 |
| 400 | msrc | 1 |
| 401 | +hsc | 1 |
| 402 | phenylethyl-itc | 1 |
| 403 | 1.31°c | 1 |
| 404 | 35-41°c | 1 |
| 405 | 30-32.5°c | 1 |
| 406 | 600mg/d | 1 |
| 407 | pacemaker-induced | 1 |
| 408 | confided | 1 |
| 409 | underprovided | 1 |
| 410 | re-recorded | 1 |
| 411 | re-packed | 1 |
| 412 | undercontrolled | 1 |
| 413 | ushered | 14 |
| 414 | overwintered | 2 |
| 415 | ccurred | 1 |
| 416 | musculoskeletal-based | 1 |
| 417 | fibroblast-based | 1 |
| 418 | 'embarrassed | 1 |
| 419 | simvastatin-used | 1 |
| 420 | retranslocated | 1 |
| 421 | cooled/heated | 1 |
| 422 | non-access-related | 1 |
| 423 | capitulated | 1 |
| 424 | 14-coordinated | 1 |
| 425 | reduced/eliminated | 1 |
| 426 | culminated | 53 |
| 427 | nonsmokers-participated | 1 |
| 428 | misgrated | 1 |
| 429 | resulted | 16,468 |
| 430 | reality-oriented | 1 |
| 431 | implimented | 1 |
| 432 | euverted | 1 |
| 433 | nanoencapsuted | 1 |
| 434 | 5-heptyl-substituted | 1 |
| 435 | rowed | 1 |
| 436 | iodid | 1 |
| 437 | gezondheid | 1 |
| 438 | 4-steroid | 1 |
| 439 | ~70-fold | 1 |
| 440 | 0.54-fold | 1 |
| 441 | 7.54-fold | 1 |
| 442 | 84-fold | 1 |
| 443 | ∼135-fold | 1 |
| 444 | 0.65-fold | 1 |
| 445 | ~2.7-fold | 1 |
| 446 | ~27-fold | 1 |
| 447 | 3.37-fold | 1 |
| 448 | amiodarone-and | 1 |
| 449 | responsibilities-and | 1 |
| 450 | hemolysis-and | 1 |
| 451 | darkness-and | 1 |
| 452 | maccleod | 1 |
| 453 | grizzard | 1 |
| 454 | gabbe | 1 |
| 455 | irctimbalance | 1 |
| 456 | over-exuberance | 1 |
| 457 | -resistance | 3 |
| 458 | 2-chloro-n-methylacetamide | 1 |
| 459 | 2-bromoacetamide | 1 |
| 460 | azintamide | 1 |
| 461 | monosialoganglioside | 1 |
| 462 | 4-phenylsemicarbazide | 1 |
| 463 | leucyl-histidylhydrazide | 1 |
| 464 | 3,4,5-trimethoxybenzaldehyde | 1 |
| 465 | 3-ethoxy-4-hydroxybenzaldehyde | 1 |
| 466 | up-stage | 1 |
| 467 | cost/change | 1 |
| 468 | plausibility.the | 1 |
| 469 | b/yamagata/16/88-like | 1 |
| 470 | edendale | 1 |
| 471 | sociale | 1 |
| 472 | encourageable | 1 |
| 473 | irreproductible | 1 |
| 474 | ser80-to-ile | 1 |
| 475 | thr105ile | 1 |
| 476 | early-diastole | 1 |
| 477 | 3-amino-5-hydroxypyrazole | 1 |
| 478 | nifuroxime | 1 |
| 479 | allyltrimethylsilane | 1 |
| 480 | glycyltryptophanylglycylglycine | 1 |
| 481 | argpyrimidine | 1 |
| 482 | cefroxidine | 1 |
| 483 | desmethyl-clomipramine | 1 |
| 484 | phenylyalanine | 1 |
| 485 | ca/creatinine | 1 |
| 486 | carbamezepine | 1 |
| 487 | phenyle-phrine | 1 |
| 488 | vigabatrine | 1 |
| 489 | glucosine | 1 |
| 490 | artesunate+amodiaquine | 2 |
| 491 | 3,6-dichlorotetrazine | 1 |
| 492 | 3-bromo-4-hydroxy-2h-chromen-2-one | 1 |
| 493 | drug-alone | 1 |
| 494 | 17beta-trenbolone | 1 |
| 495 | muconolactone | 1 |
| 496 | 1,3-diphenylacetone | 1 |
| 497 | kawangware | 1 |
| 498 | ahr/xre | 1 |
| 499 | lipoperoxidase | 1 |
| 500 | beta-1,3-glucanase | 1 |
| 501 | alkaliphosphatase | 1 |
| 502 | hendrickse | 1 |
| 503 | maltodextrin-glucose | 1 |
| 504 | 3-o-ac-l-rhamnose | 1 |
| 505 | 3,6-anhydrogalactose | 1 |
| 506 | 5-methylterahydrofolate | 1 |
| 507 | ibotenate | 1 |
| 508 | galacturonate | 1 |
| 509 | toparticipate | 1 |
| 510 | interpenetrate | 1 |
| 511 | freeze-concentrate | 1 |
| 512 | 'aggravate | 1 |
| 513 | 18-hete | 1 |
| 514 | entente | 1 |
| 515 | intervente | 1 |
| 516 | trivette | 1 |
| 517 | under-achieve | 1 |
| 518 | ex-pensive | 1 |
| 519 | exacerbative | 1 |
| 520 | absent/negative | 1 |
| 521 | mycoplasmas-positive | 1 |
| 522 | jin-ye | 1 |
| 523 | 1,2,3,7,8-pebdf | 1 |
| 524 | 3d-ef | 1 |
| 525 | 0.1g/g | 1 |
| 526 | 4.1g/g | 1 |
| 527 | t80a-a90g | 1 |
| 528 | rs1176713-gg | 1 |
| 529 | 11.5±7.4mmhg | 1 |
| 530 | 179.7mg/kg | 1 |
| 531 | -0.2kg | 1 |
| 532 | 1500/mg | 1 |
| 533 | whang | 1 |
| 534 | lizhong-tang | 1 |
| 535 | s9-enhancing | 1 |
| 536 | kucing | 1 |
| 537 | lieing | 1 |
| 538 | immaging | 1 |
| 539 | conspecific-pecking | 1 |
| 540 | mglur-signaling | 1 |
| 541 | wobbling | 1 |
| 542 | brdu-labeling | 1 |
| 543 | numbness/tingling | 1 |
| 544 | re-enrolling | 1 |
| 545 | reenrolling | 1 |
| 546 | tag-positioning | 1 |
| 547 | pin-stripping | 1 |
| 548 | noise/oversensing | 1 |
| 549 | symptom-generating | 1 |
| 550 | inter-acting | 1 |
| 551 | downgrafting | 1 |
| 552 | dash-resulting | 1 |
| 553 | isting | 2 |
| 554 | underachieving | 1 |
| 555 | vortexing | 1 |
| 556 | srlong | 1 |
| 557 | 19.1h | 1 |
| 558 | p.q201h | 1 |
| 559 | gh14-3-3h | 1 |
| 560 | d165h | 1 |
| 561 | 32.6h | 1 |
| 562 | 1.4±0.7h | 1 |
| 563 | 20.8h | 1 |
| 564 | oprh | 1 |
| 565 | devilish | 1 |
| 566 | urosepsis/death | 1 |
| 567 | maibi | 1 |
| 568 | pulmonary-pleurostaphylococci | 1 |
| 569 | rietvlei | 2 |
| 570 | ikji | 1 |
| 571 | tuszyński | 1 |
| 572 | rhli | 1 |
| 573 | cinelli | 1 |
| 574 | hyperlipogensisi | 1 |
| 575 | interventi | 1 |
| 576 | hnrnp-k | 1 |
| 577 | p.v600k | 1 |
| 578 | p.e4181k | 1 |
| 579 | mate-2k | 1 |
| 580 | fahrzeugtechnik | 1 |
| 581 | phospho-syk | 1 |
| 582 | 162.2pmol/l | 1 |
| 583 | nh4+-n/l | 2 |
| 584 | ml/min/l | 2 |
| 585 | 144±69.29u/l | 1 |
| 586 | 14.8±9.0l | 1 |
| 587 | uretero-ileal | 1 |
| 588 | 2-methylbutanal | 1 |
| 589 | trans-2-hexenal | 1 |
| 590 | 115/dl | 1 |
| 591 | 9.8g/dl | 1 |
| 592 | 1.9±0.2mg/dl | 1 |
| 593 | 1.4mg/dl | 1 |
| 594 | 14.36±2.26mg/dl | 1 |
| 595 | 16.67±1.77mg/dl | 1 |
| 596 | sdldl/lhdl | 1 |
| 597 | quasi-3.36-level | 1 |
| 598 | tsh-level | 1 |
| 599 | 5-fluorucacil | 1 |
| 600 | uncoil | 1 |
| 601 | 300±100c/ml | 1 |
| 602 | 225.26±112.95ng/ml | 1 |
| 603 | 46.13±94.70pg/ml | 1 |
| 604 | 30.31±75.85pg/ml | 1 |
| 605 | 550±44.2minμg/ml | 1 |
| 606 | 642±153minμg/ml | 1 |
| 607 | 256.4±77.80ml | 1 |
| 608 | 1191.65ml | 1 |
| 609 | cineol | 1 |
| 610 | 1,2-decanediol | 1 |
| 611 | 4-dimethylaminophenol | 1 |
| 612 | 3,4-didehydroretinol | 1 |
| 613 | dihydroxycholecalciferol | 1 |
| 614 | choelsterol | 1 |
| 615 | δfm-ul | 1 |
| 616 | revengeful | 1 |
| 617 | çatağıl | 1 |
| 618 | 60,000/μl | 1 |
| 619 | fensham | 1 |
| 620 | mihjam | 2 |
| 621 | ≥90cm | 1 |
| 622 | crem | 1 |
| 623 | cedercholm | 1 |
| 624 | 6.0mm | 1 |
| 625 | 15.1mm | 1 |
| 626 | 3.7±1.3mm | 1 |
| 627 | 109.3mm | 1 |
| 628 | 5.16±1.04mm | 1 |
| 629 | 2.5-3.75mm | 1 |
| 630 | 23nm | 1 |
| 631 | sitcom | 1 |
| 632 | 11microm | 1 |
| 633 | 97microm | 1 |
| 634 | 12.60ppm | 1 |
| 635 | anapharm | 1 |
| 636 | catabolism/anabolism | 1 |
| 637 | transformation-metabolism | 1 |
| 638 | 298.40±37.77mosm | 1 |
| 639 | brainstem-cerebellum | 1 |
| 640 | secretorum | 1 |
| 641 | 82.0μm | 1 |
| 642 | 65±31μm | 1 |
| 643 | 159.5μm | 1 |
| 644 | nc-n | 1 |
| 645 | dentascan | 1 |
| 646 | swertiamarian | 1 |
| 647 | hisaralan | 1 |
| 648 | €3830/woman | 1 |
| 649 | friedrichschafen | 1 |
| 650 | urea-nitrogen | 1 |
| 651 | alpha-amino-nitrogen | 1 |
| 652 | fatten | 1 |
| 653 | nodvocain | 1 |
| 654 | resisting-pain | 1 |
| 655 | vs.vancomycin | 1 |
| 656 | deptomycin | 1 |
| 657 | zexanthin | 1 |
| 658 | dipherelin | 1 |
| 659 | haptoglobulin | 1 |
| 660 | lns/min | 2 |
| 661 | 138.0±15.0beats/min | 1 |
| 662 | 32.34±26.83min | 1 |
| 663 | y654-beta-catenin | 1 |
| 664 | i-troponin | 1 |
| 665 | low-dose-heparin | 1 |
| 666 | simvasatin | 1 |
| 667 | hypoadiponectin | 1 |
| 668 | apple-pectin | 1 |
| 669 | senataxin | 1 |
| 670 | mckhann | 1 |
| 671 | myeloperoxidation | 1 |
| 672 | micronucleation | 1 |
| 673 | bloc-ablation | 1 |
| 674 | middle-methylation | 1 |
| 675 | peer-moderation | 1 |
| 676 | myofibroproliferation | 1 |
| 677 | metallisation | 1 |
| 678 | volatisation | 1 |
| 679 | preparation-transplantation | 1 |
| 680 | pilot-implementation | 1 |
| 681 | non-supplementation | 1 |
| 682 | self-representation | 1 |
| 683 | nfκb-activation | 1 |
| 684 | rehydrolyzation | 1 |
| 685 | light-reaction | 1 |
| 686 | non-rejection | 1 |
| 687 | time-to-detection | 2 |
| 688 | uroprotection | 1 |
| 689 | diastolic-dysfunction | 1 |
| 690 | group/attrition | 1 |
| 691 | over-eruption | 1 |
| 692 | viferon | 1 |
| 693 | phosphorylated-cjun | 1 |
| 694 | isheri-igando | 1 |
| 695 | tnpo | 1 |
| 696 | 1365euro | 1 |
| 697 | sucesso | 1 |
| 698 | ambra-sinto | 1 |
| 699 | r1628p | 1 |
| 700 | cdc48p | 1 |
| 701 | 2292-bp | 1 |
| 702 | 4ebp | 1 |
| 703 | 4,6'-diacetyl-3,3'-dmbp | 1 |
| 704 | scientists/bhp | 1 |
| 705 | 0.5mamp | 1 |
| 706 | c-gmp | 1 |
| 707 | ofprp | 1 |
| 708 | gly128→asp | 1 |
| 709 | 1,4-bq | 1 |
| 710 | €/year | 1 |
| 711 | intra-canalicular | 1 |
| 712 | pieber | 1 |
| 713 | oder | 2 |
| 714 | simvastatin-differ | 1 |
| 715 | dolasetron-differ | 1 |
| 716 | mother's/mother | 1 |
| 717 | cancer-killer | 1 |
| 718 | -dimer | 1 |
| 719 | angioscanner | 1 |
| 720 | post-whisper | 1 |
| 721 | dieter | 1 |
| 722 | multiplexer/demultiplexer | 1 |
| 723 | texturizer | 1 |
| 724 | post-egfr | 1 |
| 725 | 52±0.1gr | 1 |
| 726 | ft-nmr | 1 |
| 727 | rmopr | 1 |
| 728 | rv-sr | 1 |
| 729 | mnur | 1 |
| 730 | sreepur | 1 |
| 731 | 181s | 1 |
| 732 | 130.7±33.4s | 1 |
| 733 | 58.0±6.4s | 1 |
| 734 | ttatg8s | 1 |
| 735 | madias | 1 |
| 736 | mathias | 1 |
| 737 | tulokas | 1 |
| 738 | talukas | 1 |
| 739 | ufh/vkas | 1 |
| 740 | fibropapillomas | 1 |
| 741 | hsl-mrnas | 1 |
| 742 | a2rbs | 1 |
| 743 | resorbs | 1 |
| 744 | deg/enacs | 1 |
| 745 | procinetics | 1 |
| 746 | succeeds | 15 |
| 747 | triatomids | 1 |
| 748 | gene-scaffolds | 1 |
| 749 | carers/friends | 1 |
| 750 | 2-seconds | 1 |
| 751 | post-aes | 1 |
| 752 | m-helices | 1 |
| 753 | perturbances | 1 |
| 754 | age-differences | 1 |
| 755 | rollerblades | 1 |
| 756 | arylpropiolamides | 1 |
| 757 | balanoides | 1 |
| 758 | xilooligosaccharides | 1 |
| 759 | diglucosides | 2 |
| 760 | azalydes | 1 |
| 761 | hydroxo-bridges | 1 |
| 762 | phase-changes | 1 |
| 763 | rouges | 1 |
| 764 | hot-flushes | 1 |
| 765 | bronchiectasies | 1 |
| 766 | nonstationarities | 1 |
| 767 | pseudomonadales | 1 |
| 768 | rubiales | 1 |
| 769 | wobbles | 1 |
| 770 | 3.0log10cycles | 1 |
| 771 | brachyteles | 1 |
| 772 | concentration-profiles | 1 |
| 773 | 3-sulfenyl-indoles | 1 |
| 774 | -trisindoles | 1 |
| 775 | alkylideneoxindoles | 1 |
| 776 | 3-methyleneoxindoles | 1 |
| 777 | 3-indolyloxindoles | 1 |
| 778 | microholes | 1 |
| 779 | gases/fumes | 1 |
| 780 | 1,3,5-triarylpyrazolines | 1 |
| 781 | 3-indolinones | 1 |
| 782 | anti-progesterones | 2 |
| 783 | ε-lactones | 1 |
| 784 | anilinolactones | 1 |
| 785 | enynes | 1 |
| 786 | heme-chromophores | 1 |
| 787 | bmd/markers/fractures | 1 |
| 788 | β-esterases | 1 |
| 789 | autophagic-responses | 1 |
| 790 | waitresses | 1 |
| 791 | thermostresses | 1 |
| 792 | nanoaggregates | 1 |
| 793 | microparticulates | 1 |
| 794 | participates | 249 |
| 795 | hyper-leukocytes | 1 |
| 796 | il-8-values | 1 |
| 797 | crystallizes | 91 |
| 798 | p.e767fs | 1 |
| 799 | railings | 1 |
| 800 | alkyl-pahs | 1 |
| 801 | 60.0months | 1 |
| 802 | 10.1months | 1 |
| 803 | 5.73months | 1 |
| 804 | 49months | 1 |
| 805 | goldis | 1 |
| 806 | cervicalis | 1 |
| 807 | syphillis | 1 |
| 808 | atelactasis | 1 |
| 809 | plasmacytogenesis | 1 |
| 810 | quadruparesis | 1 |
| 811 | apergillosis | 1 |
| 812 | necrosis/fibrosis | 1 |
| 813 | cholangiofibrosis | 1 |
| 814 | neosporosis | 1 |
| 815 | aggregation-thrombolysis | 1 |
| 816 | gluconeogenesis/glycolysis | 1 |
| 817 | procitis | 1 |
| 818 | sub-chorionitis | 1 |
| 819 | enteronitis | 1 |
| 820 | lymphadentis | 1 |
| 821 | metamaks | 1 |
| 822 | blicks | 1 |
| 823 | of/kinks | 1 |
| 824 | post-ecls | 1 |
| 825 | treg-cells | 1 |
| 826 | bcells | 1 |
| 827 | healthy-controls | 1 |
| 828 | mptms | 1 |
| 829 | bolivians | 1 |
| 830 | nonself-antigens | 1 |
| 831 | desmins | 1 |
| 832 | n-alkylisatins | 1 |
| 833 | ofstatins | 1 |
| 834 | nitrite-anions | 1 |
| 835 | microperforations | 1 |
| 836 | epidermal-growth-factor-concentrations | 1 |
| 837 | unsaturations | 1 |
| 838 | st-elevations | 1 |
| 839 | 5,6-positions | 1 |
| 840 | stillbirths/abortions | 2 |
| 841 | cocos/bacilos | 1 |
| 842 | pellinos | 1 |
| 843 | igfs/igfbps | 1 |
| 844 | tone-sweeps | 1 |
| 845 | dfps | 1 |
| 846 | symtomps | 1 |
| 847 | mtx-groups | 1 |
| 848 | ades/adrs | 1 |
| 849 | vad-volunteers | 1 |
| 850 | kers | 1 |
| 851 | low-likers | 1 |
| 852 | non-ring-wearers | 1 |
| 853 | nonring-wearers | 1 |
| 854 | non-acquirers | 1 |
| 855 | adc-parameters | 1 |
| 856 | vegfr2-promoters | 1 |
| 857 | multi-leaf-collimators | 1 |
| 858 | chemo-protectors | 1 |
| 859 | planterflexors | 1 |
| 860 | lh-responsiveness | 1 |
| 861 | selectiveness | 1 |
| 862 | chemorefractoriness | 1 |
| 863 | intrusion-distress | 1 |
| 864 | beta-islets | 1 |
| 865 | gender-weights | 1 |
| 866 | knights | 1 |
| 867 | provements | 1 |
| 868 | no-shunts | 1 |
| 869 | gps'reports | 1 |
| 870 | adipoblasts | 1 |
| 871 | diabetologists/endocrinologists | 1 |
| 872 | mineralocorticoid-receptor-antagonists | 1 |
| 873 | paribus | 1 |
| 874 | solidus | 1 |
| 875 | acidicaldus | 1 |
| 876 | pc-kus | 1 |
| 877 | rsus | 1 |
| 878 | pretarsus | 1 |
| 879 | triangulatus | 1 |
| 880 | nerve/plexus | 1 |
| 881 | 82days | 1 |
| 882 | 6.4days | 1 |
| 883 | foodways | 1 |
| 884 | c-550t | 1 |
| 885 | c1603t | 1 |
| 886 | osfd-gogat | 3 |
| 887 | disrtict | 1 |
| 888 | verteporfin-pdt | 1 |
| 889 | violet-light | 1 |
| 890 | dsbt-cbt-cwit | 1 |
| 891 | c.3897delt | 1 |
| 892 | bapwv/cca-imt | 1 |
| 893 | reengulfment | 1 |
| 894 | de-investment | 1 |
| 895 | bestent | 1 |
| 896 | crept | 1 |
| 897 | inductest | 1 |
| 898 | +3953tt | 1 |
| 899 | 6503deltt | 1 |
| 900 | ser65cys/wt | 1 |
| 901 | 2.7±2.2u | 1 |
| 902 | p.ser615leu | 1 |
| 903 | sanou | 1 |
| 904 | kainantu | 2 |
| 905 | penicillin-v | 1 |
| 906 | post-wbv | 1 |
| 907 | dbpcv | 1 |
| 908 | hpv/hiv | 1 |
| 909 | knowhow | 1 |
| 910 | fv1x | 1 |
| 911 | duerinckx | 1 |
| 912 | fufox | 1 |
| 913 | repeat-hltx | 1 |
| 914 | idmtx | 1 |
| 915 | 1.2mg/day | 1 |
| 916 | li-may | 1 |
| 917 | non-malignancy | 1 |
| 918 | creedy | 1 |
| 919 | cundy | 1 |
| 920 | wenereology | 1 |
| 921 | aerobiology | 1 |
| 922 | cytobacteriology | 1 |
| 923 | pharmaco-electroencephalography | 1 |
| 924 | plethsmography | 1 |
| 925 | daliy | 1 |
| 926 | €16,438/qaly | 1 |
| 927 | £10,148/qaly | 1 |
| 928 | 40,139€/qaly | 1 |
| 929 | superbroadly | 1 |
| 930 | non-coercively | 1 |
| 931 | hepatosplenomegly | 1 |
| 932 | membrane-specifically | 1 |
| 933 | urethritis-especially | 1 |
| 934 | spectially | 1 |
| 935 | intra-abomasally | 1 |
| 936 | programs-particularly | 1 |
| 937 | uniocularly | 1 |
| 938 | trerapy | 1 |
| 939 | mazury | 1 |
| 940 | synaptotoxicity | 1 |
| 941 | sparcity | 1 |
| 942 | overall-mortality | 1 |
| 943 | irreplaceability | 1 |
| 944 | alterability | 1 |
| 945 | ultrastability | 1 |
| 946 | uv-susceptibility | 1 |
| 947 | alpha-amylase-activity | 1 |
| 948 | f3'h-activity | 1 |
| 949 | retrospectivity | 1 |
| 950 | levatroplasty | 1 |
| 951 | pvwy | 1 |
| 952 | 5.46hz | 1 |
| 953 | opitz | 1 |
| 954 | h₂wo₄ | 1 |
| 955 | 1.12€ | 1 |
| 956 | murad® | 1 |
| 957 | purpald® | 1 |
| 958 | pecfent® | 1 |
| 959 | 1.25‰ | 1 |
| 960 | 8.20° | 1 |
| 961 | 6.0±2.1° | 1 |
| 962 | 2.5±6.1° | 1 |
| 963 | 45.3° | 1 |
| 964 | 3.25°±2.04° | 1 |
| 965 | 49.5° | 1 |
| 966 | 22.6° | 1 |
| 967 | 104.17° | 1 |
| 968 | ≥67° | 1 |
| 969 | 13.77° | 1 |
| 970 | 114.9° | 1 |
| 971 | 108.9° | 1 |
| 972 | 2.39° | 1 |
| 973 | +4cm² | 1 |
| 974 | lpin1-β | 1 |
| 975 | interleukin-lβ | 1 |
| 976 | ppar-α-γ | 1 |
| 977 | egfp-14-3-3θ | 1 |
| 978 | effectiveness¿ | 1 |